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ABSTRACT
This thesis describes a structural and functional study of shikimate kinase, the enzyme |
which catalyses the fifth step in the biosynthetic shikimate pathway in which shikimate is 
converted to shikimate-3-phosphate.
Mutagenesis studies were undertaken to discover more about the roles of the assumed 
catalytic residues in particular the single lysine (K15) within the active site and the 
neighbouring cysteine (C l3). The cysteine remote from the active site (C l62) was also 
mutated to prevent intermolecular disulphide formation which had previously been 
obseiwed during crystallographic studies.
Biophysical techniques including circular dichroism (CD), fluorescence and 
microcalorimetiy were used to monitor the conformational changes of shikimate kinase 
accompanying ligand binding and to measure ligand binding.
The single tryptophan (W54) was found to be a very useful fluorophore for monitoring 
conformational changes. Calculated Kd values from this compared well with the Km values 
measured by steady state kinetics. The dissociation constant (Kd) for shikimate was 300 
pM and for ATP 700 pM.
When monitored by fluorescence the binding of the ATP to the enzyme showed a degree of 
co-operativity. The data did not fit a standard Michaelis Menten binding curve but gave a 
sigmoidal plot with a Hill co-efficient of approximately 2. The binding of ADP gave a Hill 
co-efficient of approximately 1.5.
Fluorescence quenching studies using the quenching agents of succinimide and sodium 
iodide allowed the calculation of Stern-Volmer constants. The results provided information 
about the environment of the Trp-54.
ATP binding to the enzyme was also measured by Isothermal titration calorimetry (ITC)
This gave Kd values of only 25-40pM whereas apparent steady state kinetics gave a Km
Î
I
I
value of 700pM. This discrepancy has not been explained but it may reflect the existence 
of a second ATP binding site.
Thermal stability was measured using differential scanning calorimetry (DSC) which was 
analysed to give the apparent melting temperature (Tm). Ligand binding (ATP) was found 
to stabilize the structure of shikimate kinase illustrated by an increase in the Tm from 39 to 
47°C. However the shikimic acid provides a lower degree of stabilisation.
The mutant K15M had a higher Tm than the wild type enzyme; this may be due to the 
formation of an extra ion pair in the stmcture, formed between the side chains of Asp 32 
and Arg 11. Theimal stability was also measured by using CD to monitor the loss of 
secondary structure at 222nm.
Dénaturation and refolding studies were carried out using guanidine hydrochloride 
(GdnHCl) as the dénaturant.
The concentration of GdnHCl needed to bring about 50% of the total change of the native 
structure in both secondaiy, measuring the change in CD, and tertiary stmcture measuring 
the changes in fluorescence was 1.25M. This was observed as a single transition. Total 
loss of stmcture was observed at concentrations of 4M and above.
Refolding of the enzyme was monitored by both fluorescence and CD using both manual 
mixing and stopped flow techniques. The data indicated that refolding took place in a 
number of distinctive stages. One of the intermediates appeared to have a high affinity for 
the fluorescent probe l-anilino-8-napthalenesulphonate (ANS). An outline model for the I
refolding of the enzyme could be proposed.
!
1 Introduction
1.1 The Shikimate Pathway
1.1.1 Background to the Shikimate Pathway
The biosynthesis of the aromatic amino acids phenylalanine, tyrosine and tryptophan 
proceeds via the shikimate pathway. This pathway provides the aromatic amino acids along 
with other important aromatic compounds required in plants and micro-organisms (Figure 
1.1a, 1.1b).
The condensation of erythrose-4-phosphate (a product of the Calvin cycle and/or the 
pentose phosphate pathway) and phosphoenolpyiuvate (derived from glycolysis) is the first 
step in the pathway and is catalysed by the enzyme 3-deoxy-D-«mômo-heptulosonate 7- 
phosphate (DAHP) synthase. A further six steps lead to chorismate which is the common 
precursor of all the essential aromatic compounds such as folic acid and vitamin K as well 
as the major plant cell wall component lignin (Pittard, 1987; Bentley, 1990; Coggins, 1989; 
Haslam, 1993; Fig 1.1b). It has been estimated that one fifth of the carbon fixed by plants 
is channelled through the shikimate pathway (Kishore and Shah, 1988).
The pathway is named after one of the intermediates, shikimic acid, which was isolated by 
Eykmann from the fruits of Illicium religiosum over a century ago (Eykmann, 1891). The 
structure of shikimic acid was solved much later by Fischer and Danschat (Fischer, 1932). 
The elucidation of the intermediates of the pathway was carried out during work in the 
1950’s principally by Davis who studied mutants that were auxotrophic for the three 
aromatic amino acids. These auxotrophs accumulated intermediates preceding the blocked 
steps in the pathway. This led to the identification of the central pathway intermediates, 3- 
dehydroquinate, 3-dehydroshikimate and shikimate-3-phosphate (Davis, 1948, 1949,1955). 
The earlier and later reactions were elucidated with more difficulty. A mutant strain of 
Escherichia coli that accumulated shikimic acid was grown on D-glucose variously labelled
..I
14with C to determine the distribution of specific carbon atoms from glucose in the 
shikimate molecule (Gibson and Gibson, 1964). It was determined that of the seven
1.1.2 The enzymology of the shikimate pathway
The first enzyme of the shikimate pathway is DAHP synthase which catalyses the
precursor carbon atoms entering the pathway tliree originated from the glycolytic pathway 
and four originated fiom the pentose phosphate pathway. Cell extracts and partially 
purified enzyme preparations were shown to convert phosphoenolpyruvate and erytlirose-4- 
phosphate to DAHP and then 3-dehydroquinate (DHQate). The position of 5-efîo/pymvyl 
shikimate-3-phosphate synthase (EPSPS) in the pathway was determined from the 
conversion of shikimate 3-phosphate and phosphoenolpyruvate to S-e^ro/pyruvyl shikimate- 
3-phosphate (EPSP) by cell extracts. Chorismate itself was first characterised by Gibson 
and Gibson (1964).
' j
condensation of the carbohydrate precursors of phosphoenolpyruvate and erythrose-4-
phosphate. In a second step catalysed by 3-dehydroquinate synthase, DAHP is cyclised to 
give 3-dehydroquinate. The third step is carried out by the enzyme 3-dehydroquinate 
dehydratase (loiown more commonly as dehydroquinase) and involves the elimination of 
water from the cyclised DAHP; this introduces the first double bond to produce 
dehydroshikimate. Subsequent reduction of the keto group by the action of shikimate 
dehydrogenase produces shikimate in step four. Shikimate is then converted to shikimate 
3-phosphate by the phospho-transfer activity of shikimate kinase in step five. The sixth 
step involves the condensation of phosphoenolpyruvate and shikimate-3 -phosphate
catalysed by the action of EPSP synthase yielding EPSP, the substrate for the final enzyme 
of the pathway, chorismate synthase.
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Figure 1.1a : The Shikimate Pathway.
Chorismate synthase, which catalyses the seventh step, introduces the second double bond 
and produces chorismate which is the branch point intermediate leading through parallel 
pathways to the aromatic amino acids and the other aromatic compounds (Figure 1.1b).
The pathway intermediates and enzyme reactions that occur within the shikimate pathway 
are believed, with the single exception of dehydroquinase (Kleanthous et ai, 1992; Hanis 
et al, 1993), to be identical in all organisms. Although the catalytic domains are highly 
conserved at the protein level the genes and the opérons responsible for the production of 
the enzymes are in fact organised differently in different species, probably reflecting 
contrasting evolutionaiy histories and the functional and regulatory constraints experienced 
by each species (Henner and Yanofsky 1993).
I
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1.1.3 The individual enzymes of the shikimate pathway
1.1.3.1 3-Deoxy-D-«m6//îo-heptuIosonate 7-phosphate synthase 
DAHP Synthase (EC 4.1.2.15)
The first committed step in the biosynthesis of aromatic compounds is catalysed by DAHP 
synthase is the condensation of phosphoenoipyruvate and erythiose-4-phosphate. The flow 
of metabolites, as within any biosynthetic pathway, is regulated by feedback inhibition 
brought about by intermediates or end products. In fact DAHP synthase shows a rather 
complex method of feedback regulation which is different between E. coli and Bacillus 
subtilis. In E. coli and Salmonella typhimurium there are tliree independent DAHP 
synthase isoenzymes, phenylalanine sensitive DAHP synthase (phe), tryptophan sensitive 
DAHP synthase (trp), and tyrosine sensitive DAHP synthase (tyr). Each aromatic amino 
acid therefore has the ability to affect the flux through the pathway and mutants with
I
varying levels of this resistance to feedback inhibition have been isolated (Pittard, 1966). 
However in B. subtilis only one DAHP synthase exists which is not inhibited by the 
aromatic amino acids but rather by prephenate which is an intermediate of phenylalanine 
and tyrosine synthesis (Jensen and Nasser 1968; Jensen and Nasser, 1968; Jensen, 1976). 
An excess of phenylalanine and tyrosine results in the feedback inhibition of prephenate 
dehydratase blocking the further conversion of prephenate. This build-up of prephenate 
inhibits the DAHP synthase and reduces the flow of metabolites into the shikimate pathway 
(Jensen and Ahmad, 1988).
This type of sequential feedback strategy could potentially starve the cells of tryptophan, 
the synthesis of which branches fi*om chorismate. However, chorismate mutase, which 
catalyses the conversion of chorismate to prephenate is inhibited by the product prephenate 
and this is suggested to be sufficient to channel chorismate into the tryptophan pathway 
(Henner and Yanosky, 1993).
1.1.3.2 3-Dehydroquinate synthase (EC 4.6.1.3)
The oxidation, (3 elhnination and intermolecular condensation to convert DAHP to 3- 
dehydroqiiinate is carried out by 3-dehydroquinate synthase for which the presence of 
NAD^ as cofactor is required.
In E. coli this enzyme is a monofunctional polypeptide of molecular mass 40kDa which 
requires NAD”^ and Co^  ^ or Zn^  ^ for activity (Frost, 1984). The enzyme is expressed 
constitutively as with the other enzymes of the pathway except shikimate kinase. In B. 
subtilis however 3-dehydroquinate synthase was purified with chorismate synthase and 
NADPH-dependent flavin reductase (Hasan and Nester, 1978). The enzyme was only 
active when associated with chorismate synthase whereas the presence or absence of the 
flavin reductase has no effect on the dehydroquinate synthase activity. The enzyme requked 
NAD"  ^and either Co^ "^  or Mn^^ for activity.
1.1.3.3 3“Dehydroqumate dehydratase (dehydroquinase) (EC 4.2.1.10)
3 “Dehydroquinate dehydiatase catalyses the third step in the shikimate pathway and is 
responsible for initiating the process of introducing the first double bond, thus generating 
dehydroquinate. There exists two classes of dehydroquinate dehydratase (type I and type 
II) which catalyse the reactions with opposite stereochemistry (Kleanthous et a/., 1992; 
Harris e? a/., 1993).
The reaction is common to the two metabolic pathways, namely (i) biosynthesis to generate 
the aromatic amino acids in micro-organisms and plants and (ii) the catabolic quinate 
pathway in fungi (Figure 1.2) which allows the use of quinate as the sole carbon source 
(Giles et al., 1985).
1Type I DHQase is only involved in the biosynthetic pathway (Chaudhuri et a l, 
1985,1987a,b) whereas type II enzymes have been found to have either a biosynthetic 
(White et a l, 1990; Garbe et a/., 1991; Bottomley et a/.,1996) or catabolic role (Hawkins, 
1982).
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Figure 1.2 : The position of dehydroquinate as the Intermediate In the
biosynthetic shikimate and catabolic (quinate) pathways.
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Both E. coli and S. typhi possess type I DHQase which generates a Schiff base intermediate |
'S '
(Shneier et al, 1991) while the type II DHQase exemplified by the Mycobacterium 
tuberculosis and Streptomyces coelicolor enzyme work via an enolate mechanism (Harris et 
al, 1996). The crystal structures of both enzymes have now been solved and extensive 
characterisation has been performed (Gourley et al, 1996 ; Price et al, 1999).
Interestingly B. subtilis appears from the genome sequence to have both types of DHQase; 
this possibility presently bemg investigated by Alex Herbert, University of Glasgow,
(personal communication).
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1.1.3.4 Shikimate dehydrogenase (EC 1.1.1.25)
Shikimate dehydi'ogenase catalyses the reversible reduction of 3-dehydroshikimate to 
produce shikimate and is an NADF^ specific dehydrogenase. The E. coli enzyme has 272 
amino acids and exists as a monomer of molecular mass of 29 kDa. The enzyme was found 
to be strongly selective for NADPH over NADH (Balinsky et aZ.,1971).
There are two kinds of pyridine nucleotide dependent dehydrogenase enzymes, those with 
or without catalytically active metal ions such as Zv?^ and (Aronson et a l, 1989).
Shikimate dehydrogenase is believed to be a metal independent dehydrogenase similai* to 
lactate dehydrogenase (LDH) and malate dehydrogenase (MDH). The enzymes have an 
essential active site histidine residue which forms a hydrogen bond with the carbonyl group 
of the substrate (Adams et al, 1987). This then initiates the hydride ion tiansfer by 
polarisation of the carbonyl group. In metal dependent dehydrogenases such as alcohol 
dehydrogenase such a transfer is initiated by the bound metal ion.
In shikimate dehydrogenase the presence of EDTA does not inhibit activity and the 
presence of divalent ions has no activating effect on the enzyme activity; thus it belongs to 
the metal independent category.
■'■f'
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1.1.3.5 Shikimate kinase (EC 2.7.1.71)
Shikimate kinase (SK) is the fifth enzyme in the shikimate pathway which catalyses the 
phospho-transfer firom ATP to the C-3 hydroxyl group of shikimate.
This enzyme which is the subject of the thesis is reviewed in section 1.3 below.
1.1.3.6.1 5"e«o/pyruvy!shikimate-3“phosphate synthase (EPSP synthase)
(EC 2.5.1.19)
5-e«o/pyruvylshikimate-3-phosphate synthase (EPSPS) is responsible for the transfer of the
enolpymvyl moiety from phosphoenoipyruvate to shikimate-3-phosphate forming 5- 
e«o/pyruvylshikimate-3-phosphate and inorganic phosphate.
In E. coli the polypeptide has 427 amino acids with a subunit molecular mass of 46 kDa 
and is monomeric (Duncan et al, 1984), The enzyme from B. subtilis has 428 amino acids 
and is also monomeric (Henner et al, 1986).
This enzyme is targeted by the broad spectrum herbicide glyphosate and is discussed in 
section 1.6.1.
1.1.3.7 Chorismate synthase (EC 4.6.1.4)
(S-Phospho-S-enolpyruvylshikimate phosphate-lyase)
Chorismate synthase catalyses the final step in the shikimate pathway the conversion of 5-
enolpyruvylshikimate-3-phosphate to chorismate. This involves the abstraction of the 6-
pro-R-H and elimination of phosphate which then generates the second double bond within
the aromatic ring. For each reaction a reduced flavin co-factor is required as is shown by
the Neurospora crassa enzyme which possesses an intrinsic NADPH-dependent flavin 
,oxidoreductase (Welch et a l , 1974; Boocock and Coggins, 1983; Henstrand et a l , 1995).
:;sy-î:
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The enzymes in E, coli (White et a l, 1988) and B. subtilis (Hasan and Nester, 1978) are 
monofunctional and must be supplied exogenously witli reduced flavin.
The isolation, purification and characterisation of these enzymes has been difficult as they 
naturally occur within cells at low concentrations. However the advent of recombinant 
DNA technology has made it possible to constmct overproducing strains of E. coli which 
can cope with a 1000 fold increase in the expression of a particular protein which in some 
cases, can lead up to 50% of the total cellular protein within the cell (Studier and Moffatt, 
1986).
With this teclmology the isolation, expression and characterisation of all the enzymes 
involved in the pathway has been carried out.
1.2 Organisation of the Shikimate Pathway Enzymes
Although the seven enzymes of the shikimate pathway are structurally and mechanistically 
similar in all species capable of aromatic amino acid biosynthesis the genetic arrangement 
is rather different.
The genetic arrangement varies greatly from E. coli where the seven enzymes exist as 
separate monofunctional genes (Berlyn and Giles, 1969; Nakatsukasa, and Nester, 1972, 
Rothe, 1983; Pittard, 1987) to the multi-functional complex that is found in the fungal 
species; Neurospora crassa (Lumsden and Coggins, 1977; Giles, 1985;), Aspergillus 
nidulans (Kinghorn and Hawkins, 1982), Saccharomyces cerevisiae (Duncan et al, 1987; 
Graham, 1993) and other fungal and yeast species such as Euglena gracilis (Patel and 
Giles, 1979) where five of the seven activities are linked on one gene in one single open 
reading frame and are known as AROM clusters (Duncan et a l, 1987; Charles, 1985 and 
1986).
A
In plants however there exists no AROM cluster but a bifunctional arrangement of 
dehydroquinase and shikimate dehydrogenase, found during extensive studies on 
photosynthetic organisms by Berlyn (1969;1970,72,73) and more recently in Pisum sativum 
(Deka et al, 1994). Differences within such ‘isoenzymes’ have led to interest in the 
evolutionaiy history and the biochemical pathway origins of these. Enzymes could therefore 
be used as ‘documents of the course of evolution’ (Haslam, 1993).
■‘1
f.1
Enzyme Gene Map
Position
(min)
Amino
acids
Subunit
Mr
Quaternary
Structure
DAHP Synthase 
DAHP Synthase (tyr) aro F 57 356 38,804 dimer
DAHPSynthase (phe) aroG 17 350 37,997 tetramer
DAHP Synthase (trp) aroH 37 347 39,000 dimer
3-Dehydroquinate synthase aroB 75 362 38,880 monomer
3-Dehydroquinate dehydratase aroD 37 240 26,377 dimer
Shikimate dehydrogenase aroE 72 272 29,380 monomer
Shikimate kinase 1 aroK 74 173 19,526 monomer
H aroL 9 173 18,937 monomer
EPSP synthase aroA 20 427 46,112 monomer
Chorismate synthase aroC 51 357 38,183 tetramer
I
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Table 1.1 : Arrangement of the shikimate pathway genes In E, coli
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Escherichia coli Salmonella typhimurium Bacillus subtilis
Neurospora crassa Aspergillus nidulans Euglata gracilis Saccharomyces cerevisiae
Piston sativum Physcomitrella patens
MouoAmc*kmal
Multifaartioiuil
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Figure 1.3: Showing the genetic arrangement of the genes for the
Shikimate Pathway.
1.3 Shikimate Kinase
1.3.1 Reaction mechanism of shikimate kinase
Shikimate kinase (SK) (E.C. 2.7.1.71) is the fifth enzyme in the shikimate pathway which 
catalyses the phospho-transfer fi*om ATP to the C-3 hydroxyl group of shikimate.
CO2-
OHH O '
OH
Shikimate
CO]-
+ MgADP"
OH
OH
Shikimate- 3 -phosphate
Figure 1.4 : Reaction mechanism of shikimate kinase
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Shikimate kinase I (SKI) however is independent of both the amount of exti'acellular amino 
acid and the level of the tyrR gene product (Ely and Pittard, 1979).
One other aro gene which is not subject to the tyrR repression or to end product repression 
is aro B the gene for dehydroquinate synthase the second enzyme of the shikimate pathway. 
The aroK gene encoding the SKI was located upstream of the aroB gene (L0bner-Olsen 
and Marinus, 1992; Whipp and Pittard, 1995). These genes form another two gene operon.
1.3.3 Eîîzyiïiology of the two isoforms of shikimate kinase
The gene for SKII was cloned and over expressed and found to be a monomer of molecular 
mass of 18 937 Da (Millar et al, 1986; De Fey ter and Pittard, 1986a). The apparent Km 
for shikimate was 200 pM and 160pM for ATP (De Feyter and Pittard, 1986b). SKI has 
been shown to have a much lower affinity for shikimate compared to that of SKII, having a
13
'I1.3.2 Background to the molecular biology of the two isoforms of shikimate kinase
Two isoforms of shikimate kinase (SK) exist, types I and II. This is unusual for enzymes 
that exist in the middle of a pathway which has led to the proposition that shikimate may be 
a branch point intermediate (De Feyter et al, 1986).
Both the aroK gene encoding SKI and aroL encoding SKII are scattered around the 
chromosome at the positions shown in Table 1.1,
SKII expression is controlled through the aroL existing in a two gene operon aroLM which 
is regulated by the trpR and tyrR regulator gene (Ely and Pittard, 1979; De Feyter et al, 
1986). The tyrR protein is of particular interest since it modulates the expression of at least 
eight unlinked opérons. Seven of these opérons are regulated in response to co-factors to 
the tyrR protein and they foim an active regulatory system.
-g:
Km of 20mM. Between these monomers there is 30% sequence similarity and both are 173 
amino acids in length. The role for SKI is still unclear; It has been suggested that SKI has 
been displaced by the catalytically more efficient and better regulated SKII (DeFeyter and 
Pittard, 1986c). It is possible that SKI is not involved in shikimate biosynthesis, since it 
only phosphorylates shikimate foituitously (DeFeyter and Pittard, 1986b), and that it has a 
completely different role (or roles) in the cell. SKII may be involved in the 
phosphorylation of a small molecule rather than a protein (Snell, 1996). The reported 
sensitivity of SKI to the antibiotic mecillinam is suggestive of an alternative biological role 
(Vinella et ai, 1996). In B, subtilis 168 there is a single SK which forms a complex with 
DAHP synthase; when this complex is dissociated the shikimate kinase becomes inactive.
1.4 Structural comparisons to other known kinases
It has been shown through comparisons of sequence and crystal sti*ucture data that there is a 
degree of sequence consei*vation in a number of nucleotide binding proteins (Walker, 1982; 
Moller and Amons, 1985; Fry et a l, 1986; Dever et a l, 1987; Saraste et a l, 1990). The 
region most conserved is the glycine rich domain which forms a loop between the |3-strands 
and the a- helix (Wierenga and Hoi, 1983; Gay and Walker, 1983; Schulz et a/., 1990; 
Muller and Schulz, 1992, 1993). Generally this motif is referred to as the A motif or P-loop 
having the consensus sequence AG-X4-GKST (Walker et al, 1982). It contains the 
essential lysine in the motif GK(T/S) which is thought to generate an anionic environment 
within which the [3-phosphate of ATP can be accommodated. Crystal structure analysis of 
the guanidine nucleotide binding proteins EFTu and p21 and the enzyme adenylate kinase 
have revealed that this structural motif indeed constitutes a loop which wraps around a 
phosphate group (Dreusicke and Schulz, 1986,1988).
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1AROM Aspergillus Nidulans I G M R 6 A 6 K S T A  GNWVSKAL
AROM Saccharomyces cerevisiae I  G M R A A G K T T  I SKWCASAL
aro L Erwinia Chrysanthemi V G A R G C G K T T V  GRELARAL
aro L E. coli I G P R G C G K T T V  GRELARAL
Figure 1.5: Sequence similarity within the P-loop binding domain of
shikimate kinase.
The highly conserved lysine present in this P-loop has been studied extensively both from a 
crystallographic viewpoint (Pai, 1977; Muller and Schulz, 1993,1996) and with chemical 
modifying agents and site directed mutagenesis (Tian et al, 1988, 1990). The mutagenesis 
of the shikimate kinase in this project parallels the mutagenesis work that was carried out 
on adenylate kinase (Tian et a l, 1990) where the two lysines present in adenylate kinase 
were mutated to methionine. More recently mutagenesis of the lysines seen in human 
adenylate kinase have been studied (Ayabe, 1997; Bertrand et a l, 1997a b).
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Shikimate kinase I (SKI) from Erwinia chrysanthemi has been shown to have a very similar 
fold to that of adenylate kinase, yet with only 19% sequence homology (Krell et a l, 1998). 
The structure consists of five {3-strands and eight a-helical regions and the sequence 
contained a Walker type A motif (GXXGXGK(TZS). The ‘invariant’ lysine together with 
the glycine rich loop within this motif has been shown to be conserved among 64 sequences 
of nucleotide binding proteins known. (Hanks et a l, 1988).
.^1
Figure 1.6: The P-loop domain illustrating the active site lysine (K15) and 
the position of the bound ADP in shikimate kinase II 
from Erwinia chrysanthemi.
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Trp 54
Shikimate binding site
Figure 1.7 : The complete full structure of shikimate kinase indicating
regions of the P-Loop and the shikimate binding domain.
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1.5 The induced fit mechanism of enzyme action
Large conformational changes are often noticed within NMP kinases during catalysis. Such
‘4ligand induced conformational changes which were first described by Koshland for the 
enzyme phosphoglycerate mutase (Koshland, 1959, Yankeelov and Koshland 1965) and 
such changes are described by the term ‘induced f lf . Induced fit with the NMP kinases 
occurs within the two flexible regions of the enzyme namely the nucleotide binding domain 
and the lid domain. This occurs for a number or reasons; to protect the active sites and 
substrates from the omnipresent water and avoid principally ATP hydrolysis, as well as the 
saturation of the active sites with substrates and prevention of the escape of the 
intermediates generated. The actual movement has been described in detail by Schulz and 
his colleagues who solved a series of crystal structures of adenylate kinase with different 
bound ligands (Muller et al, 1996; Schulz et a/., 1990; Gerstain et a/., 1993 and Sinev,
1996ab; Smirnova et al, 1998). Rotation of the body of the enzyme by 39° and then a lid 
domain movement of 30° together with a hinge bending rotation of 90° was observed; a 
‘movie’ of the total changes has been produced (Muller et al, 1996).
i,
1.6 Importance of studying the shikimate pathway enzymes.
Mammals do not possess the capacity to synthesise the aromatic amino acids via the 
shikimate pathway. Much interest therefore, has focused on the opportunity for selectively 
blocking the shikimate pathway enzymes within potentially pathogenic organisms and thus 
develop potential herbicidal (Coggins, 1989), antibacterial (Davies et a l, 1994) and anti-
parasitic agents (Roberts et a l , 1998).
41
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range of possible inhibitors based on the structure of glyphosate is being studied 
intensively.
1.6.2 (6S)“6“FIiioro“Slîikiraic acid
(6S)“6"Fluoro-shikimic acid, an analogue of shikimic acid, was reported as a potential 
antibacterial agent for use in human medicine (Davies et a l, 1994; Ewart et al, 1995). 
This compound was initially thought to act by inhibition of chorismate synthase 
(Baiasubramanian et a l, 1991) but more recently it has been suggested that it acts by 
inliibiting p-aminobenzoate synthase (Bornemann et a l, 1995).
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1,6.1 Glyphosate
The active agent in the leading herbicide Round-Up is glyphosate which specifically 
inhibits the sixth enzyme of the pathway 5-g^o/pymvylshikimate-3-phosphate synthase 
(EPSP synthase) (Steinmcken and Amrhein, 1980; Amrhein et al, 1983; Boocock and
J
Coggins, 1983). It is a non-selective, broad spectrum and post-emergence herbicide which 
inhibits the synthesis of the aromatic amino acids through competitive inhibition of the
'IEPSP synthase. The mechanism, however for such inhibition is not yet fully understood.
More recent papers (Roberts et a l, 1998) have identified the toxic action of glyphosate
Iupon apicomplexan parasites including Toxoplasma gondii, Plasmodium falciparum and 
Crytosporidium parvum which have only recently been found to have the shikimate Ï.
pathway. Genetic engineering techniques have been used to make glyphosate-resistant crop
plants (Comai et a l, 1985) and they are now widely grown in the United States (Padgette et f
fa l, 1995). There are a few examples of plants becoming ‘naturally’ resistant to the effects
of glyphosate but to date the emergence of such resistance has been very rare (Reinbothe et 
al, 1993). Recently some alternative inhibitors have been reported (Shah et a l, 1997).
Although there are examples of plants becoming immune to the effects of glyphosate, a |
1.7 The principal biophysical methods used in this work 
1.7.1. Circular Dichroism
Circular Dichroism (CD) is a specti'al technique based on the differential absorbance of left 
and right circularly polarised components of plane polarised radiation. CD is the result of 
chromophores that are themselves chiral (optically active) or are placed in an asymmetric 
environment. Radiation is split into two circularly polarised components, by being passed 
through a modulator such as a piezoelectric crystal, which is subject to an alternating 
electric field. If the two components are not absorbed by the sample or are absorbed to the 
same extent then no CD signal will be produced. If however one of the polarised 
components is absorbed to a greater extent than the other (e.g. due to intrinsic or 
environment chirality of a chromophore) then the resulting radiation would be eliiptically 
polarised, for example, instead of a plane an ellipse will be traced out. In practice the two 
components are not recombined after passage through the sample; the Instrument actually 
measures the change in absorbance.
The term ellipicity (referring to the theoretical recombination) is widely used. From the 
degree of ellipicity it is possible to relate the signal obtained to structural information. The 
relative proportions of a-helix and p-sheet in a protein can be determined ftom signals 
obtained in the far UV CD arising from the peptide bonds
In the far UV CD (a wavelength below 250nm) the a-helix and p-sheet secondary 
structures determine the spectral characteristics largely due to the chirality exhibited around 
the peptide bond. In the near UV CD (250nm-350nm) the spectrum gives a detailed ‘finger 
print’ of the tertiary structure of a protein largely as a result of the environments of each 
aromatic amino acid side chain although there are contributions from disulphide or non­
protein co-factors that may be present. CD has been used ever increasingly as a rapid way 
of studying structural changes brought about upon binding of ligands and can give
20
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information about the folding and stability of the protein in question. For a more detailed 
review of circular dichroism and its applications see Kelly and Price (1997). Is41.7.2 Fluorescence
Protein fluorescence can be used to monitor changes in protein tertiary structure.
In proteins, aromatic amino acids (essentially tryptophan residues) are able to emit 
fluorescence. This fluorescence occurs when a molecule is excited by radiation. The 
molecule then decays from its excited state, and the excess energy is released, at a longer 
wavelength. Protein fluorescence is largely due to the excitation of aromatic amino acid 
residues particularly tryptophan which has a maximum emission at 356nm (in water) after 
excitation at 290nm (Price, 1972),
4
Shikimate kinase has a single tryptophan residue which has proved to be a usefiil 
fluorophore for monitoring conformational changes associated with ligand binding. The 
changes in fluorescence reflect changes in the environment of the tryptophan.
Burial of the fluorophore within a protein or shielding by other amino acid residues leads to 
a blue shift in the wavelength of the emission maximum. The quenching of protein 
fluorescence, after ligand binding, is particularly useful for providing information on the 
conformational changes that occur following ligand binding.
During unfolding/refolding studies the regain of protein fluorescence can be used as an 
indicator as to the extent of regain of tertiary structure. The denatured, unfolded, protein has f
an emission maximum of 356nm, indicative of a fully exposed tryptophan. During 
refolding, the emission maximum will shift to the blue as the tryptophan residues become f
buried or sheltered within the protein.
I
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1.7.3 Differential Scanning microcalorimetry (DSC)
Differential Scanning microcalorimetry (DSC) is an experimental technique used to 
measure the heat energy uptake that takes place in a sample during a controlled change in 
temperature. The simplest level of using DSC is in the determination of the melting 
temperature for samples in solution although thermodynamic parameters can also be
i:.
calculated. As the protein is heated at a constant rate in a calorimeter cell an identical 
reference cell containing buffer is also heated. The differences in apparent heat capacity 
can be then determined (Cooper et al, 1999) along with the theimodynamic parameters 
(AHcal,AHv-H).
The whole folded protein is also only marginally more stable than the unfolded foim. Thus
:! :
the conformational stability of almost all naturally occurring globular proteins is between 5 
and 15 kcai/mol (21 and 63 kJ/mol) (Arfin and Bradshaw, 1988).
Ligand binding may well have a substantial effect on the conformational stability of a
protein which will generate differences in Tm and thermodynamic parameters.
Large binding constants that exist in strong to ultratight protein interactions, which caimot
be conveniently measured by conventional equilibrium techniques, have been elucidated by
.means of DSC (Brandts and Lin, 1989 and 1990). The ionic strength of buffers used during 
DSC may have an effect on the stabilisation of a protein and this has been investigated by 
looking at the stabilisation that Zn^  ^ offers carboxypeptidase B (Conejero-Lara et al,
1991). The effect that the scan rate has on the dénaturation of yeast phosphoglycerate 
kinase (Galisteo et al, 1991) has been studied. The formation of enzyme ligand complex 
via a Schiff base formed in the catalytic mechanism of dehydroquinase type I has been 
shown to have marked effects on the stability (Kleanthous et al, 1991).
4
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1.8 Aims of this project ;
1) generation and purification of a number of site directed mutants of shikimate kinase
2) characterisation of the binding of ligands to these mutant proteins.
3) characterisation of the unfolding and refolding of shikimate kinase
4) assessment of the significance of the results in relation to models of both substrate 
binding and protein folding.
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1.7.4 Isothermal Titration Calorimetry (ITC)
Isothermal titration calorimetry (ITC) is a technique which provides a means of measuring 
affinity constants which can help to provide a complete thermodynamic characterisation of 
the system under study. ITC provides a great deal of physical information about the
■i
binding process including the binding affinity or equilibrium constant (K«q), the molecular 
ratio or stoichiometiy (n) and the heat or enthalpy (AH) as well as entropy (AS) of binding.
The enthalpy of binding, the stoichiometry and the free energy change (AG) of the binding
process are determined by a non linear fit of the binding isotherm (Cooper et al, 1998). i
'4Titration calorimetry is a more practical approach to the routine determination of 
thermodynamic parameters because nearly all binding interactions are accompanied by a ^
change in enthalpy and thus viitually all reactions of interest will produce a calorimetric 
signal. Titration calorimetry offers the possibility of directly deteimining not only the 
association constant and free energy but also the stoichiometry, enthalpy and entropy in a 
single experiment.
I
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2 Materials and Methods
2.1 Materials
2.1.1 Reagents
Most reagents were purchased ftom the Sigma Chemical Company, Dorset, England or 
Fisher Scientific. These were of ANALAR grade or of the highest grade available.
Tryptone, yeast extract and bacto-agar were obtained from OXOID Ltd, Basingstoke
Hampshire, England..
Agarose was purchased from Life Technologies Inc. Gaithersburg, MD 20877 U.S.A. and 
guanidinium choride was purchased from GIBCO BRL Life Technologies, Paisley,
Scotland.
t
2.1.2 Proteins and Enzymes
Restriction enzymes and VentR DNA polymerase were obtained from New England Biolabs 
Incorporated, Hitchin, Hertfordshire, England; Promega Corp, Southampton, England and 
Boehringer Mannheim, UK.
Bacteriophage T4 DNA ligase and calf intestinal alkaline phosphatase, were purchased 
from Promega Corp., Southampton, England.
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2.2 Bacterial culture strains, plasmids and oligonucleotides
2.2.1 Bacterial strains
Bacterial strain Genotype
Escherichia coli DH5a F" (|)80d/acZAM15 recAI endAl gyrA96 thi-J hsdRJ7{r^'
mk^j supE44 relAl deoR A{lacZYA~argF)\]\69
Escherichia coli F“ ompT hsdSs ra ,niB‘ dcm gal A.DE3
BL21(DE3)pLysS Studier and Moffatt (1986)
2.2.2 Bacterial plasmids
Plasmids Reference
pTB361 Protein Expression Plasmid Zeneca Patent application 4
no 92301456.8 j?■5;:
2.2.3 Synthetic oligonucleotides
The primers were obtained from GENOSYS (Genosys Biotechnologies Europe Ltd.).
Primer Sequence Length
(bp)
SKPrA 5’GAA GGA GAT ATA CAT ATG ACA GAA CCC 3’ 27
SKPrB 5’GCA TTA CAO ATC TCA GGC CGC AGG CAG ACG 3’ 30
K15M For 5’GGG TGC GGA ATG ACC ACC GTC GGC 3’ 24
K15MRev 5’ GCC GAC GGT GGT CAT TCC GCA CCC 3’ 24
C13S For 5’GGC GCC AGA GGG AGC GGA AAA ACC 3’ 24
C13S Rev 5’GGT TTT TCC GCT CCC TCT GGC GCC 3’ 24
C162S For 5’CCC GCC GCG ATT GTC AGC GAA TTG ATG 3’ 27
C162SRev 5’CAT CAA TTC GCT GAC AAT CGC GGC GGG 3’ 27
D34N For 5’GGC TAT GAG TTT GTC GAT ACG AAT ATT TTT ATG CAG 3’ 36
D34N Rev 5’CTG CAT AAA AAT ATT CGT ATC GAC AAA CTC ATA GCC 3’ 36
The bold letters indicate the mutated base
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2.3 Growth and storage of micro-organisms
2.3.1 Culture media
Routine bacterial growth was caiTied out in Luiia-Bertani (LB) medium comprising; bacto- 
tryptone lOg/liti’e, yeast extract 5g/litre and NaCl lOg/litre.
Solid media was generated by the addition of bacto-agar at a concentr ation of 1.5%.
All solutions of media were autoclaved at 15psi for 15minutes.
Antibiotics were added to the following concentration value; Tetracycline 12.5pg/ml, 
chloramphenicol 25pg/ml.
Stock solutions at 12.5mg/ml and 25mg/ml respectively were made up in 70% ethanol and 
filter sterilised through a 0.22pm millipore filter and stored at ~20°C for no longer than 2 
weeks.
Antibiotics from tlie stock solution were added to the pre-autoclaved media when the
■I.
temperature had cooled to 50-55°C.
Plates were then poured and stored at 4°C for use within 2 weeks.
2.3.2 Growth of strains
Growth was carried out routinely at 37°C. Liquid cultures were grown with shaking at 200 
rpm. Agar* plates were grown overnight in the 37°C room or in the small bench top •4
incubator.
2.3.3 Storage of strains
Short term storage was achieved by plating out the bacteria and storing plates at 4°C. In the
case of BL21 (DE3) pLysS pTB361 strain, re-streaking of plates was necessary every four 
weeks to maintain the short term storage culture.
4--
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Medium term storage of bacteria was accomplished by making glycerol stocks of overnight 
cultures with the addition of 80% (v/v) sterile glycerol to a final concentration of 15% (v/v) 
and these were stored at -20
Long term storage was achieved as above but with the cells being stored at -80°C.
2.4 Molecular biology methods
2.4.1 DNA electrophoresis
Gels electrophoresis of DNA was detected using 1% agarose gels made up in Tris-borate 
buffer (TBE) which comprised 90mM Tris, 90mM boric acid and 2niM EDTA pH 8.0. 
The agarose was melted into the buffer solution by means of a microwave and upon cooling 
down to pouring temperature 0.05pg/ml Ethidium Bromide was added.
Sample loading buffer contained 0.25% bromophenol blue and 40% (w/v) sucrose made up 
in water.
2.4.2 Plasmid restriction
Plasmid (5pg) was digested for 1 hour in a total volume of 50pl with 10-20 units of 
restriction enzyme. The supplied buffer (provided by Promega or Boehringer Mannheim) 
was used in accordance with manufacturers instructions.
5pi of the digest was mn in a 1% agarose gel. A marker of Ikb standard ladder (Gibco- 
BRL) was used to identify fragments.
For PCR reactions it was sometimes necessaiy to use a smaller marker 500bp ladder. To 
check that the digest was successful the gel was viewed under a UV transilluminator.
The restriction digest mix was then cleaned up using a Wizard DNA Clean-Up Kit 
(Promega) with the final elution of DNA into 50pl sterile water.
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2,4.3 PCR procedure; Site directed mutagenesis
2.4.3.1 Two stage PCR using Vent polymerase
PCR was used in a two stage procedure to generate site directed mutants of the enzyme 
(Higuchi et al, 1988). Great fidelity is required for the generation of specific mutations 
and thus VentR Polymerase was employed (New England Biolabs).
PCR external primers were designed upon the original multiple cloning site within the 
pTB361 plasmid. These primers incorporated the start codon (Ndel) at the 5’ end and the 
stop codon (Bgl II) at the 3’ end of the gene. Internal primers with the mis-match were 
designed with a Tm similar to that of the external primers so that any mismatching would 
not generate problems during theimal cycling.
2.4.3.2 PCR reaction mix
PCR reactions were carried out using DNA VentR polymerase with appropriate buffers and 
salts. The reaction in a total volume of lOOpl was set up comprising the following; 
lOpl of lOX reaction buffer, lOpl of lOX dNTP mix, lOOpmol of each primer, lOOng of 
DNA and lOpl of lOX supplied magnesium buffer. DNA VentR polymerase (1-2 units) 
was added for each reaction. Thin walled 200 pi PCR tubes were used within the PCR 
BioRad gene Cycler model number 10770. Thermal cycles of 3 min at 94°C (initial 
dénaturation), with cycle repeats of 94°C, 55°C, 72°C, for 1 minute each followed by a 
final extension of 2 minutes at 72°C. Thirty of these cycles were carried out.
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Figure 2.43,2; Site directed mutagenesis (Higuchi et al, 1988).
Two separate complementaiy mutant oligos are generated in the first step PCR step 
followed by a second round where the complementary fragments are able to form 
the full length mutant insert ready for re-ligation into vector of choice.
2 4.3.4 Recovery of PCR products from reactions
10 pi of the PCR product was mn on a 1% (v/v) agarose gel to deteimine whether the PCR 
reaction had produced the desired fragment and whether other secondaiy PCR products
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i.were generated. When only the desired fragment was observed, the PCR reaction mix was 'ï:
pmified using the PCR Clean-Up Kit (Promega).
The final elution was made in 50pl sterile water and lOpl of this was run out on a gel to 
check that a good recovery was obtained. These fragments could then be used for the
second round of PCR with the product of this second round, (the full length mutant insert) 
being used in the ligation mix.
concentration of 1.0 unit per pmol 3’ or blunt ends and 0.1 unit per pmol of 5’ ends. The 
molar amount of plasmid ends was calculated by; 
mass of plasmid (g) x no. of bases
Mr of plasmid (Mr of base pair = -  660)
Allcaline phosphatase tieatment took place at 37°C for a period of 30 mmutes in a total 
volume of lOOpi. The DNA Clean-Up Kit was used to purify the plasmid.
2AA.2 Ligation of cut moieties
The concentration of DNA prior to ligation was checked either spectrophotometrically or 
estimated by the intensity of bands shown in gel electrophoresis. Generally several ratios 
of vector DNA and insert DNA were used in separate ligations. Ligations were performed 
in a total volume of lOpl with 1-3 units of T4 DNA ligase and incubated at 4°C overnight.
3 0
-i
2.4.4.1 Alkaline phosphatase treatment of restricted plasmid
Calf Intestinal alkaline phosphatase (CIAP) was added to the digested plasmid at a
12.4.4.3 Plasmid isolation from colonies
Plasmid minipreps were performed using Wizard Mini™ preparations (Promega).
A single colony was used to innoculate 5 ml of fresh LB which was grown overnight with 
shaking, at 37°C. 3ml of the overnight growth sample was centrifuged and pelleted cells 
were used to isolate plasmid following the instructions in the above mini prep kit. For mass 
screening of colonies the lysozyme/boiling method of Holmes & Quigley (1981) was
I
utilised. S
2.5 Preparation of competent cells and transformation
A single colony of the appropriate strain of E, coli was picked from an agar plate or a loop 
was used to melt a small amount of culture from the top of a glycerol stock. This was used 
to inoculate a 20ml volume of LB which was then grown overnight at 37°C. From the 
overnight growth 2ml was used to inoculate 100ml fresh LB in a 250ml flask. The cells 
were grown at 37°C and with 200rpm shaking until they reached mid log phase 
(OD55o=0.35~0.5). The cells were then chilled on ice and centrifuged in a Beckman Model 
J-6B at 3,000g for 5 minutes at 4°C. The pellet of cells were then resuspended in 1/10
volume in sterile ice cold transformation buffer 1 (TFBl) (lOOmM RbCl, 50mM MnCL, |
30mM KCl, lOmM CaCli and 15% glycerol, added to water in sequence and then made to 
pH 5.8 with dilute acetic acid and filter sterilised). Incubation in the TFBI took place for 90 
minutes on ice after which the cells were centrifuged as before for another 5 minutes.
The pellet was then resuspended in TFB2 (lOmM MOPS, lOmM RbCl, 75mM CaCla and 
15% glycerol, adjusted to pH 7.0 using HCl and filter sterilised), 1/40 of the original 
starting volume of culture.
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2.5.2 DNA Sequencing
The Molecular Biology Support Unit located in the Glasgow University campus was 
utilised for all sequencing runs. The Perkin Elmer ABI Prism™ Dye Terminator Cycle 
Sequencing Core Kit with Amplitaq®DNA Polymerase. Samples were prepared using 
QIAGEN mini preps for DNA isolation and the standard T7 primer together with internal 
primers specific for the known gene sequence were used.
The amount of DNA template was between 0.5-l.Opg and primer concentiation was 
3.2pmol. The procedure involved 25 cycle repeats of 96°C for 30secs, 50°C for 15secs and 
60°C for 4mins.
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The resulting cells were then stored in 200pi aliquots ready for immediate use or snap 
frozen in a dry-ice/ethanol bath and stored at -80°C for an indefinite period without 
showmg any significant reduction in transformation efficiency.
2.5.1 Transformation protocol
An aliquot (200pi) of frozen competent cells was slowly defrosted between thumb and 
finger prior to use then replaced back on ice.
The 10 pi ligation mix was added to the cells and gently mixed putting the aliquot back on 
ice for a further 30 minutes. The cells were then heat shocked at 37°C for 90 seconds and 
replaced back on ice for 15 minutes. 800pl of LB was added to tlie cells (to bring the 
volume up to 1ml) and then incubated at 37°C for 60 minutes. Transformation controls 
were performed at the same time following the sample procedure minus the addition of 
DNA. Cells were centrifuged at full speed for 30 seconds prior to re-suspension in 50- 
lOOpl fresh LB and plated out on selective plates.
"S:
2.6 Expression of proteins
2.6.1 Expression in pTB361
The expression plasmid pTB361 is a cer tei^ plasmid which contains a consenus T7 
promoter immediately upstream from a multiple cloning site.
The inclusion of the gene for T7 lysozyme (which binds and inhibits T7 RNA polymerase) 
on plasmids pLysE and pLysS provides a means of controlling the basal levels of expressed 
protein prior to induction with ÏPTG. pLysS plasmid has the lysozyme gene inserted in the 
inverse direction to the tet promoter producing lower levels of enzyme and allowing greater
mRNA production (Studier and Moffatt, 1986). These plasmids are compatible with
pTB361 and confer chloramphenicol resistance. BL21(DE3) is ompT , Lon which may 
help to prevent proteolysis during purification procedure (Studier and Moffatt 1986).
The lysozyme produced from the pLysS plasmid is sufficient to enable lysis during either
3 3
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freeze-thaw or mild Triton treatment.
2.6.2 Protein expression
A 20ml overnight culture was prepared by selecting a colony from the expression strain of 
E. coli BL21 (DE3) pLysS pTB361 SK either the native or mutant variety.
On the following day the 20ml overnight culture was used to inoculate 500ml of fresh LB, 
containing the appropriate antibiotics, contained in a 2.5 litre flask. This was then grown 
overnight for preparation for the larger scale (5 litre) growth.
10 flasks each containing 500ml of fresh LB was inoculated with 35ml LB from the 500ml ?
overnight growth. These were then incubated until the appropriate growth 
(ODeoo ~ 0.500) was achieved. IPTG was then used to induce the protein expression and 
the flasks left to grow for a ftirther 4 hours.
Harvesting the cells was achieved by centrifugation at 4,500g at 4°C for 15 minutes.
The cell paste was then transferred to an appropriate container and stored at -20°C.
2.6.3 SDS PAGE
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
essentially as described by Laemmli (1970).
Acrylamide gels were made up using 70% (w/v) acylamide and 30% (w/v) bis-acrylamide; 
3% stacking and 15% running gel. Polymerisation was achieved by the addition 0.03% 
(v/v) TEMED and 0.05% (w/v) ammonium persulphate. The running buffer comprised 
Tris-HCl (3g/l), glycine (15g/l) and SDS (lg/1). Samples were denatured by boiling for 5 
minutes after dilution in the loading buffer comprising 60mM Tris/HCl, pH 6.8, 2% (w/v) 
SDS, 20% (w/v) glycerol, 15% (v/v) (3-mercaptoethanol and 0.0025% (w/v) bromophenol 
blue.
2.6.4 Protein staining
Protein was visualised on the polyaciylamide gels after staining with Coomassie blue. 
Coomassie reagents was prepared with 0.1% (w/v) Coomassie Brilliant Blue R-250 in 10% 
(v/v) glacial acetic acid, 25% (v/v) methanol. Destaining was performed with several 
changes of a 10% (v/v) glacial acetic acid, 10% methanol solution.
2.6.5 Protein estimation
The methods of Lowiy (1972) and Bradford (1976) were used to estimate protein 
concentration prior to preparing the protein solution for SDS-PAGE.
A premixed low range protein molecular weight marker (Boehrmger Mannheim) was used 
to estimate the molecular mass of proteins on the gel, by comparison of the relative distance 
of migration with the markers of known molecular masses.
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2.7 Protein purification of shikimate kinase
The purification protocol was based on a modification of that used for the purification of 
the E. coli shikimate kinase enzyme (Millar et al, 1986). The method (Krell et a l ,1991) 
required the presence of the dead end complex involving a substi'ate product mix of 
shikimate and ADP. However this method was adapted by reducing the salt concentration 
so as to prevent the protein from precipitating.
All steps after cell breakage were performed at 4°C. E. coli BL21 (DE3) pLysS pTB361 
cells (lOg) were resuspended in 20ml of buffer A (35mM Tris/HCl, 5mM KCl, 2.5mM 
MgClz and 0.4mM DTT, pH 7.5). The French Press was used to break the cells using two 
passes at a force of 950 psi. The material was then diluted to 100ml and centrifuged at 
100,000g for 1 hour.
The supernatant fi-om this was loaded directly onto the pre-equilibrated DEAE anion 
exchange column (30cm x 2.6cm diameter, flow rate 20ml/hr).
The column was then washed with buffer A until the absorbance at 280nm was below 0.3.
Elution of shikimate kinase was achieved using a linear gradient of 800ml 0-300mM KCl
: :
with a flow rate of 48ml/hr and a fractions volume of 12ml.
Pooled fractions were made up in to 1.2M (NH4)2 SO4 by the addition of solid (NFDz SO4 
these were applied to a phenyl Sepharose hydrophobic interaction column pre- equilibrated 
in buffer B (lOOmM Tris/HCl, 0.4mM DTT, pH 7.5). Elution was performed by using a
"4gradient of 400ml 1.2M-0.0M (NH4)2 SO4 with a flow rate of 20ml/hr and a fraction 
volume of 6ml.
Pooled fractions were then dialysed overnight against buffer C (35mM Tris/HCl, 500mM 
KCl 2.5mM MgCh and 0.4mM DTT, pH 7.5). This material was then concentrated by 
vacuum dialysis and glycerol added to 10% (v/v).
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After concentration to a volume of 2 ml or less the sample was loaded onto the pre­
equilibrated Sepharose 200 (superfine grade) column (120cm x 2.5cm) and eluted at a flow 
rate of 14mI/hour.
Fractions containing shikimate kinase activity were then pooled and dialysed against buffer 
C containing 50% glycerol stored at -20 °C.
2.8.2 Circular dlcliroisin
For a more detailed review of circular dichroism (CD) and its applications see Kelly and 
Price (1997) and references therein.
Folding of lysozyme was the first to be analysed using the CD method and in fact many 
thousands of proteins have had their str uctures analysed through the process of dénaturation 
and refolding.
1
2.8 Methods of analysis
2.8.1 Shikimate kinase assay
The assay for shikimate kinase was monitored 340nm. The assay depends on the coupling 
of the ADP formed to the pyruvate kinase and lactate dehydrogenase reactions, thereby 
leading to the oxidation of NADH which can be then measured at 340nm. Routine assays 
were carried out at 25°C in fleshly made assay buffer (50mM triethanolamine pH 7.2, 
50mM KCl, 5mM MgCb).
The assay consisted of the following of ATP SmM’*', NADH 0.2mM, shikimate 1.6mM*^  
and phosphoenolpyruvate (PEP) ImM 
(^ indicating neutralisation to pH 7.0 prior to storage at -20°C).
3 6
mix.
2.8.3 Fluorescence studies
2.8.3.1 Preparation for fluorescence analysis
The protein was again dialysed extensively into buffer A prior to use. Fluorescence scans 
were carried out during dénaturation using the same protein as was set up for circular 
dichroism.
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s2.8.2.1 Preparation for CD analysis
Shikimate kinase was dialysed exhaustively into buffer A (35mM Tris/HCl, 5mM KCl, 
2.5mM MgCh, 0.4mM DTT, pH 7,6). Buffer A was used throughout the proceeding 
analytical protocols described and the enzyme concentration was varied for different
experiments.
During near UV CD experiments 1 mg/ml protein concentrations were required whereas for 
work in the far UV CD 0.2-0.5mg/ml was required.
CD measurements were made at 20°C using a JASCO J-600 spectropolarimeter.
For the dénaturation profiles 8M guandinium chloride (GdnHCl) was made up in buffer A 
and appropriate volumes used to achieve the required molarity within the 1ml dénaturation
6 
.Refolding studies required much less protein for steady state analysis where the final 
concentration after dilution was only 0.09mg/ml for both CD and fluorescence work.
However for the stopped flow work larger volumes were required because of the larger 
volumes required to use the equipment. The stock concentration in this case was 1 mg/ml
which would be diluted 10 fold for a series of runs.
A series of cells of pathlengths 0.5cm 0.05cm and 0.02cm were used in the experiments 
above depending on the concentration of protein.
■2.8.5. 1) Differential scanning calorimetry (DSC)
2) Isothermal titration calorimetry (ITC)
Experiments were carried out in collaboration with Professor Alan Cooper, University of
Glasgow, Biophysical Chemistry Group,
2.8.5.1 Differential scanning calorimetiy (DSC)
The thermal dénaturation of shikimate kinase was monitored using the metliod of DSC. The 
stabilisation provided by the binding of the nucleotides ATP, ADP and the dead end mix of 
ADP/shikimate to a number of shikimate kinase samples was determined by means of Tm 
and also thermodynamic constants. Protein ligand interactions have been monitored 
extensively in Cooper et al, (1998, 1999).
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The fluorimeter was set up using the excitation wavelength of 290nm, emission was 
recorded at 350nm and the sample loaded in a 1cm pathlength cell.
Fluorescence measurements were made at 20‘^ C using a Perkin-Elmer LS50B 
spectrofluorimeter.
2.8.4 Stopped flow CD and fluorescence
Stopped-flow measurements of the refolding process were made on an Applied 
Photophysics SX-17MU stopped-flow reaction analyser with a 10:1 mixing ratio.
In the CD mode the instrument used an umbilical cell which involves a dead time estimated 
as 8ms by using the well characterised refolding of lysozyme after dénaturation.
Enzyme solution was made up at a concentration of 1 mg/ml in 4.8M and 2.8M GdnHCl and 
this enzyme mix was used to fill syringe A. Syiinge B was filled with 10ml of the 
appropriate refolding or control buffer.
Î
3 9
'1
■fi"
i/Protein samples (Img/ral ; 0.050mM) were exhaustively dialysed against buffer A and 
degassed briefly before loading into the DSC cell. All substrates were dissolved in dialysis 
buffer and the pH adjusted to pH 7.6. The rate of temperature increase was 50®C/hour over 
the range 20-90^C. Data collected were analysed using Microcal software.
2.8.S.2 Isothermal titration calorimetry (ITC)
The binding of nucleotide (ATP or ADP) to shikimate kinase samples at 25°C was 
determined using a Microcal OMEGA isothermal titration calorimeter following standard 
procedures (Wisemann, 1989, Cooper and Johnson, 1994). Protein samples (1 mg/ml ;
O.OSOmM) were exhaustively dialysed against buffer A (as above section) and degassed 
briefly before loading into the ITC cell. Substrate (ATP or ADP) as dissolved in dialysis 4
buffer and pH adjusted to pH 7.6.
A typical titration experiment involved a series of up to 25 x lOpl injections of ligand into 
the enzyme solution at 3 minute intervals with continuous stiiTing. Integrated heat effects 
on sample and controls were under identical conditions and analysed by standard 
techniques using Microcal ORIGIN software (1998).
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Chapter 3 : Initial characterisation of mutants of shikimate kinase.
'3.1 : Identification of the active site lysine in shikimate kinase II from
Erwinia chrysanthemi
3.1.1 Abstract
The crystal structure of shikimate kinase (Krell et a l, 1998) suggested a number of 
different sites at which mutations could provide useful information.
Firstly the surface cysteine (C l62) is involved in the dimérisation of the shikimate kinase; 
mutation of this residue would then permit the generation of different crystallisation 
conditions. The single lysine (K15) proved a good target to illustrate that this was indeed a 
very important residue in the active site and to investigate its role in co-ordination of the 
nucleotide substrate.
The ion pair thought to occur due to the interaction of the single lysine (K15) and the 
nearby cysteine (C l3) was investigated through mutagenesis of the C13 to a serine. The 
activities of the mutant enzymes generated was in the order of wild-type>C 162S>C 13 S 
where K15M and D34N had undetectable activity using the standard assay procedure.
The removal of the surface cysteine of C162S generated a much more soluble protein 
compared with tlie wild type. The activity of this mutant however was very similar to that 
of the wild type, however mutation of the internal cysteine (C13S) reduced the activity by 
50% compared with wild type.
The lysine mutant had undetectable activity, however, it has recently been crystallised (John 
Maclean, University of Glasgow, Personal communication) which has allowed significant 
refinement to the previous crystal structure (Krell et al, 1998).
3,1.2 Introduction
Site directed mutagenesis has become a very important and now relatively simple tool to 
explore the structural and functional significance of particular residues within proteins. 
This may involve the introduction of virtually any mutation at any site involving single base 
substitutions, short deletions or inserts. The use of this technique has grown enormously 
over the past ten years allowing us unlimited access to the manipulation of protein structure 
at the genetic code level.
A general review (Bordo and Argos, 1991) highlights the main aims of why such 
manipulation is required largely for;
1) identifying catalytic or structurally important residues: as will be illustrated in later 
chapters.
2) developing synthetic, novel genes for ease of expression in host organisms for much 
easier access to the particular protein of interest (Brocca et al, 1998)
3) regulation of genes for industrial processes both with relation to controlling flux 
pathways for specific intermediates or end products of a pathway (Dell and Frost, 1993; 
SmW etal, 1996).
4) engineering enzyme specificity to cope with novel substrates or simply to improve 
catalytic turnover (Sinistena, 1996).
In this study the first point above was investigated, looking at the catalytic and structurally 
important residues and identifying the properties of single substitutions within shikimate 
kinase. For further review on other applications the other references highlighted above 
should be consulted.
In order to investigate and identify the catalytic residues it is important that no other 
unforeseen effect has been caused by mutation. Thus only one residue was substituted at a 
time. Extensive study into the ‘safe substitutions’ that are allowed within a protein were
4 1
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4investigated using the A, repressor and the codon most preferred for the mutant protein
designed with reference to the highly and lowly biased gene table (Bulmer, 1988; 
Andersson and Kurland, 1990).
The choice of mutants to be made in shikimate kinase was selected from knowledge of the 
three dimensional stmcture of the enzyme. Multi-alignment programmes were used to align 
sequences and thus highlight conserved residues across a number of shikimate containing 
organisms which rely on the shikimate pathway.
In the alignment (Fig 3.1) it is possible to see well recognised nucleotide binding consenus 
sequences such as the Walker type A motif (Walker et al, 1982) between residues 10 and
I
20 which contained the single ‘invariant’ lysine.
Firstly, however the removal of the ability of the shikimate kinase to form a disulphide 
bond was investigated by looking at the external cysteine (C l62). This had been found to 
form a disulphide bond durmg previous ciystallisation trials and was thought to be the main 
contributing factor accounting for the lack of density around the lid domain (Fig 3.2). Thus 
removal of the possibility of disulphide bond formation may bring about more favourable 
crystallisation conditions. A ‘safe’ mutation for this was selected to be serine and thus the 
mutant C162S was generated. i
Secondly, the single lysine within shikimate kinase structure (K15) was thought to be 
essential for catalysis so a mutation analogous to that made of adenylate kinase (Tian et al,
I1990), where the two lysines were mutated to methionine (K21M and K27M), was carried ££■
out resulting in the mutant K15M of shikhnate kinase.
In order to learn more about the catalytic mechanism of shikimate kinase other residues
'itargeted were C l3 and D34. Firstly the C l3 was thought to contribute to the ion pair
4formation with the neighbouring lysine (K15) and thus a conversion of the cysteine to
serine generating C13S was selected as a third mutant. The C13S mutant was hoped to
4 2 i
have little effect on the overall activity of the enzyme since serine residues exist in the 
catalytic triad mechanism, investigated greatly, in the mechanism of the serine and thiol 
proteases.
Investigation of this series of mutants C162S, K15M, C13S expression and purification 
provide the basis of this chapter.
4 3
Ï
D34N was generated in order to identify the effect that would occur if the active site 
magnesium was to be dislodged. The change from an aspartic acid to an asparagine is a 
rather drastic mutation which would perhaps knock out the ability of the aspartic acid to 
form the ligand with the free magnesium.
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Figure 3.1 : Muiti alignment of a number of shikimate kinases (I and II)
highlighting conserved regions.
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Figure 3.2: Dimer of shikimate kinase formed by the disulphide bond
between the external cysteines (C162) highlighted in yellow.
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3,1.3 Methods
Full information regarding the methods involved in generating the site directed mutants has 
been given in material and methods section 2.4.
The final mutant PCR products were cloned into pTB361 and amplified in E. coli DH5a.
The resulting plasmid was purified and sequenced. The confirmed mutated plasmid was 
then used to transform E. coli BL21 (DE3) pLysS. Protein expression from this inducible 
strain was monitored.
Colonies that showed good expression were used to generate approximately lOg of cells in 
a large 5 litre growth. Purification then followed using the method in section 2.7. There 
were no major changes to the protocol for the purification of wild type and that of the 
mutant proteins except that during purification of the mutants K15M and D34N the 
fractions containing the enzyme were detected using SDS-PAGE since the enzyme activity
4
was undetectable in the standard assay. Fractions containing the over-expressed protein I
were pooled and the purification protocol continued.
Î.
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3.1.4 Results
5 M 8 9 M
%' % A -  97.4
-  66.24» M
-  45.0
I, -f- #k 
=% jf. *
W. j#k *IMTWRl&tPR
-  31.0
-  14.4
kDa
Figure 3.3 : SDS-PAGE over-expression gel showing the ability of the
mutant plasmids to express shikimate kinase.
All samples were taken 4 hours after induction with IPTG and prepared as
described in method and materials section 2.6.3.
Lane M : Molecular weight markers
Lane 1 and 6  : BL21 (DE3)pTB361pWT SK (15pl, lOpl)
Lane 5 : BL21 (DE3) pTB361pWT SK (5pl)
Lane 2 and 7 : BL21 (DE3)pTB361pC13S SK (15pl, lOpl)
Lane 3 and 8  : BL21 (DE3)pTB361pK15M SK (15pl, lOpl)
Lane 4 and 9 : BL21 (DE3)pTB361pC162S SK (15pl, lOpl)
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Figure 3,4 : The near UV CD spectra of shikimate kinase.
Dash ; K15M, dot; C13S, dot/dash; C162S and the solid line 
is the native shikimate kinase.
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Figure 3.5 : The far UV CD spectra of the; wild-type: solid line,
C13S:dot, K15M:dash shikimate kinase.
Enzyme a-helix (%) p-sheet (%) remainder
(%)
Wild type 29 + 0.69 26 + 1 .2 46 + 1.5
C162S 22 ± 2.3 40 + 3.5 38 + 5.3
C13S 24 + 2.8 42 ± 4.2 35 + 6.4
K15M 21 +1.3 33 + 2.2 46 + 2.7
Table 3,1 : CONTIN analysis of secondary structure content of wild 
type and mutant shikimate kinases from the far UV CD.
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3.1.5 Crystallisations
Prior to crystallisation the enzyme was exhaustively dialysed into lOmM Tris/HCl, pH 7.5, ■7
.0.5mM DTT and then concentrated to a concentration of 15mg/ml using Centricon-10 |
I'concentrators (Amicon, Stonehouse, Gloutershire, UK). Crystals were grown by Dr. John 
Maclean using varying conditions. The dead end complex containing the substrate/product 
mix was set up using 2.5mM of shikimate and ADP with a final concentration of lOmM 
MgCl2. Sitting drop vapour diffusion was used to obtain the crystals with the protein 8-
7lOmg/ml and pH readjusted to pH 7.5. 2pl of protein with equal volume of reservoir 
solution. Crystals of C162S mutant were obtained in 20% PEG 600, lOOmM Tris pH 8.6,
;2.5mM ADP, 2.5mM Shikimate, 0.5mM DTT, for K15M the resulting solution which 
generated crystals was 10% PEG 8000, lOOmM Tris pH 8.0, 2.5mM ADP, 2.5mM 
Shikimate, 0.5mM DTT.
The structure of the K15M mutant was solved by molecular replacement using native 
shikimate kinase (Krell et aL, 1997). Two K15M molecules were found in the asymmetric 
unit which were essentially identical and these when compared to the original shikimate 
kinase wild type showed an almost perfect alignment (Fig, 3.6),
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Figure 3.6 : Overlay of the K15M structure (purple) with the native 
(blue) shikimate kinase.
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Enzyme KmOrK/
(Shikimate)
pM
Kin or K(i 
(ATP) 
pM
kcat
(sec*^ )
kcat /Kin
(shikimate)
E, coli
SKI 2 0 ,0 0 0 " - - -
SK II 2 0 0 " 160" 2 7 .f 1.36 X 10®
E. chrysanthemi
wild type 307 / 700* 620 / 2560* 34.7 1.29 X 10®
C162S 282 670 40.1 1.62 X1 0 ®
C13S 75 235 /1  530* 2 2 .6 3.42 X 10®
KISM 670* 620* n.d. n.d.
D34N n.d. n.d. n.d. n.d.
Table 3.2: The kinetic parameters of wild type and mutant shikimate
kinase type II from E. chrysanthemi compared with E, coli 
isoenzymes I and II,
Km values were obtained using Lineweaver Burk plots. The assay 
mix to measure Km (shikimate) contained 5mM ATP and 3mM 
shikimate for Km (ATP).
a) Values taken from De Feyter and Pittard (1986), b) Averaged 
values values talcen from Millar et al. (1986).
*Kd values gained from fluorescence quenching experiments they 
represent the disscociation constants of one ligand in the absence of 
other ligands (see Chapter 4). n.d. not determined.
5 2
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3,1.6 Discussion
structure of the mutant enzymes, varies very little in the percentage of alpha-helical 
stixicture present. This is perhaps the most important analysis from the far UV CD as it 
illustrates that the core protein structme is unaffected by the mutant changes. The overall 
values gained for the beta sheet and remainder percentages may suggest a slight 
perturbation of the structure but the crystallography data clearly indicates that no major 
change has taken place (Fig. 3.6).
The mutagenesis of C l62 was based upon the premise that it was the cause of the 
dimérisation seen within the crystallographic unit cell. Removal of this ability therefore
5 3
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7.;The host strain E. coli (BL21 (DE3) pLysS) containing the mutant plasmids were able to
grow and express shikimate kinase at much the same level as the wild type as seen on SDS- 
PAGE (Fig 3.3). The mutant enzymes could then purified as the wild type (see material and 
methods section 2.7). It was, however, rather difficult to isolate and purify the K15M and 
D34N mutants because of their very low catalytic activity. Thus purification was 
monitored by means of SDS-PAGE with fractions containing a band of the correct 
molecular mass pooled for subsequent purification. The D34N mutant was shown to be 
unstable except in the presence of 20% glycerol. The properties of this mutant were not 
investigated in detail.
Results of the tertiary and secondary stmcture as shown in Fig 3.4, 3.5 and Table 3.1 
illustrate the overall similarity of the stmctures of the wild type, C13S, C162S and K15M 
enzymes. The CONTIN analysis, (discussed in Kelly, 1997) (Table 3.1) of the far UV
would hopefully result in more favourable ciystallisation conditions. Although the C162S
.mutant was not crystallised in this work it was possible to see that the enzyme was five fold
5 4
more soluble than the wild type. Kinetic parameters of the C162S mutant were very similar 
to the wild type.
The C13S mutation had only a slightly reduced kcat value but was shown by analysis of the ■’i
steady state kinetics and fluorescence measurements to bind both substrates with a higher 
affinity (See Table 3.2).
In the crystal structure the aspartic acid (D34) was seen to bind the shikimate and stabilise 
a water molecule for co-ordination of the essential magnesium ion. Thus, a rather drastic 
mutation to asparagine involving a change in charge type would be expected to lead to the 
loss of metal ion binding and thus result in reduced capacity to bind the nucleotide.
Although crystallisation trails have been carried out with these mutants unfortunately these 
have not generated any crystals for diffraction.
The K15M mutant however, was crystallised in the method described in section 3.1.5. 
Unfortunately, in the crystallised material, it appeared that another mutation had occurred 
although this had not been apparent from in the earlier mass spectrometric analysis of the 
purified material. A proline to leucine mutation at position 116 was detected.
However, the crystal structure of the K15M mutant is essentially super-imposable on that of 
the wild type showing only slight perturbation around the P-Loop where the methionine has 
caused tlie arginine 110 in the lid domain to move 2.7 Angstroms towards it. Another ion 
pair formed between Asp32 and Argl 1 can be seen in the K15M mutant may underlie the 
increased stability that is observed in this mutant. This is discussed in greater detail in 
chapter 5.
of the tryptophan in shikimate kinase II from Erwinia chrysanthemi.
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Chapter 4 Fluorescence studies on shikimate kinase
4.1 Use of fluorescence quenching to study the environment and mobility
4.1.1 Abstract
The quenching agents Nal and succinimide were used to quench the intrinsic fluorescence 
of the single tryptophan that exists within shikimate kinase (W54). When comparing the 
two sets of quenching data it became apparent that an increase in the Stern-Vohner constant 
(Ksv) and thus the ability of the Nal to quench the tryptophan fluorescence, compared with 
the neutral compound succinimide, was due to the presence of three positively charged 
arginines within a distance of 0.5-1,1 nm of the tiyptophan.
4.1.2 Introduction
The degree of fluorescence quenching of tryptophan residues by various reagents has been 
exploited to yield valuable information about the conformation of proteins (Freifelder, 
1976).
.The general mechanism for the quenching of an excited state luminescent state A* by 
quencher Q is ;
A* + Q A* —Q A + Q + A
The quenching of the tryptophan (fluorophore) is dependent on its exposure to the quencher 
and the environment in which it resides. Conformational changes that occur due to the 
binding of ligands may increase or decrease the exposure of the tryptophan and thus result 
in a change in the fluorescence (Eftink and Ghiron, 1976). The accessibility of the
fluorophore to the solvent is indicated by the magnitude of the Stern-Volmer constant (Ksv) 
value (shown overleaj^.
FI
Flcxp(V [Q])
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1 + Ksv [Q] s
Where FI is the original fluorescence value, Flexp is the recorded fluorescence after each 
aliquot of quencher, V  is volume of quencher, [Q] is the concentration of quencher and 
Ksv is the Stem Volmer constant for the dynamic quenching process.
Sodium iodide (Nal), acrylamide and succinimide have all been used as quenching agents 
(Eftink and Ghiron, 1976). Nal itself is a polar compound, acrylamide and succinimide are 
neutral compounds, succinimide being about 20% larger than the acrylamide as calculated 
from Van der Waals atomic increments. By calculating the Ksv ratios measured from 
quenching studies using succinimide and acrylamide, the exposure of the tryptophan can be 
assessed (Eftink and Ghiron, 1984).
I
"i
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4,1.3 Methods
Shikimate kinase was dialysed for 2 hours in Buffer A (35mM Tris/HCl, 5mM KCl, 2.5mM 
MgCb, 0,4mM DTT pH 7.5) to a concentration of about 1.5-2 mg/ml.
The final concentration of enzyme used in each quenching experiment was 0.2mg/ml.
Stock concentrations of quencher; Nal, succinimide and acrylamide were made up at 2M in 
the appropriate buffer.
Fluorescence measurements were carried out as described in the material and methods 
(Section 2.8.3) using a Perkin Ehner LS50B spectrofluorimeter. Excitation wavelength of 
290 nm and emission wavelength of 350nm were used. The values were obtained from the 
READ mode setting and collected every 5 seconds after the addition of lOpl of the 2M 
stock concentration of quencher. The values were corrected for the effect of dilution and 
then used to construct the Stern-Volmer plot (Fo / Fcoit vs. [Q] ). The slopes of this plot 
gives the Stem-Volmer constant (Ksv).
4.1.4 Results/Discussion
u,
uf
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Figure 4.1: Stem-Volmer plot showing the quenching of shikimate
kinase by Nal (A) and succinimide (B).
Stem-Volmer constants (Ksv) of 18.68 M“' and 6.56 M'  ^
respectively.
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Enzyme Nal (2M)* 
(KsvM-')
Succinimide(2M)*
(KsvM-')
Acrylamide(2M)*
(KsvM-*)
1
5
E, chrysanthemi SKII
wild type (wt) 18.68 6.56 9.51
wt + ADP (2mM) 15.42 5.63 8.70
wt + shikimate (2mM) 5.49 3.87 5.82
wt +ADP + shikimate (2mM) 3.88 3.09 3.56
Table 4.1; The calculated mean Stern Volmer constants (M"^ ) for the
fluorescence quenching of shikimate kinase fluorescence in the 
absence and presence of ligands.
* Quenching agent used
The data shown above in Table 4.1 illustiate a common bend in the Ksv values obtained 
with each quenching agent in the presence of added ligands. This trend represents a 
decrease in Ksv indicating that the tryptophan is becoming less accessible to the quenching 
agent. The magnitude of Ksv for succinimide in the absence of ligands indicates that the 
tryptophan is quite highly exposed to the solvent (Idziak et al., 1997). This conclusion is 
consistent with the value of the fluorescence emission maximum (350nm) which is close to 
that of tryptophan model compounds (356nm). There is however a relatively small 
difference between the wild type alone and wild type in the presence of 2mM ADP, thus 
indicating that the nucleotide brings about little if any structural change in relation to the 
position of the tryptophan.
5 9
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However in the presence of 2mM shikimate the Ksv is reduced considerably thus indicating 
that the binding of shikimate causes a significant change in the environment of the 
tryptophan indicating that it has become significantly less exposed to the solvent.
There is also a change in the fluorescence emission maximum of the enzyme from 350nm 
to 345nm m the presence of 2mM shikimate as seen in standard fluorescence scans, in
addition the circular dichroism spectra of the enzyme in the presence of shikimate also 
indicate some secondary structure changes (data not shown). In the dead end complex
*
(ADP-shikimate) an enhanced effect is seen and the Ksv values is at its lowest value
g(3.09M for succinimide) indicating that the tiyptophan is at its least accessible. It is 
interesting to note the fact that the Nal in the above case has the greatest Stern-Volmer |
constant and this in fact is higher than that seen with the model compound N- |
acetyltryptophan amide (NATA). The reason for this was apparent from inspection of the 
crystal structure (Krell et o/., 1998). As can be seen in Figure 4.2 there are three positively 
charged arginine residues within lOnm of the tryptophan residue which clearly attract the 
negatively charged iodide ion leading to enhanced quenching.
The three arginine residues (Arg 58 (5nm), Arg 11 (9nm), Arg 139(10nm); distances from 
the tiyptophan residue are mentioned in brackets) surrounding the tryptophan (W54)
Igenerate the electrostatic density depicted in the upper right red region in Fig 4.2. n
The removal of the positively charged environment provided by the arginines however can 
be brought about by the perturbation of structure and one way to do this is by introducing a 
denaturing agent. Addition of 2M guanidinium chloride (GdnHCl) a chaotiopic agent was 
used to disrupt the protein structure. When the quenching experiment was carried out in the 
presence of 2M GdnHCl the resulting Stern-Volmer constant was reduced to 5.80 M‘^  in 
the case for Nal, a value similar to that observed for the titration with succinimide.
Figure 4.2 : Electrostatic surface representation of shikimate kinase.
Blue and red regions represent positive and negative potential. Surface 
charge was calculated using GRASP (Gourley et al., 1994)
The positively charged environment around W54, is illustrated as the upper red region on 
the right lobe (A more precise location of the W54 was given in the introduction section 
Figure 1.7). The positive potential in this region clearly accounts for the enhanced 
quenching seen with Nal. This agent had been originally thought to be only able to quench 
completely exposed tryptophan residues due to the fact that Nal is hydrated and charged 
(Eftink and Ghiron, 1976) however these results have proved otherwise and in fact the Nal 
is able to quench, more effectively, the tryptophan which lies in a positively charged 
environment. More detailed analysis on model compound with tryptophan located in a 
positively charged region may prove interesting regarding this finding.
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4.2 Binding of substrates to shikimate kinase
(V4.2.1 Abstract
•;h
Shikimate kinase undergoes conformational changes upon substrate binding; this is an
'?:■example of ‘induced fit’ which was first recognized by Koshland (1959).
I
The conformational changes can be exploited to monitor the binding of substrate. For 
instance, binding of shikimate leads to substantial quenching of the fluorescence of I
shikimate kinase. From the titration of the enzyme with shikimate, the value of Kd can be 
derived as 750pM. This is somewhat higher than the apparent (300pM) for this
Isubstrate derived from an analysis of steady state kinetics. In the presence of nucleotide 
(ADP) the fluorescence titration shows that the Ka for shikimate is reduced to 320pM, a 
value close to the value obtained from kinetics. The reduction in Ka value is consistent 
with the proposal of substrate synergism.
Quenching of the fluorescence by shikimate alone gave rise to a binding curve which fitted '-r
well to a hyperbolic binding model. However the binding of nucleotide monitored by 
fluorescence quenching was rather different and could not be fitted to a hyperbolic model. ;r
The data however fitted moderately well to the Hill equation with a Hill co-efficient of 2.66 
for ATP binding and 1.58 for ADP binding.
Since the binding of nucleotides, monitored by Isotliermal titration calorimetry (ITC) gave 
binding affinities resulting in Ka values of the order of 25-40pM then a possible explanation 
for this behaviour and the previous result gained for the Hill equation could be the presence 
of a second nucleotide binding site.
'A
t
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4.2.2 Introduction
Substrates upon binding may cause sti-ucture alterations in the protein of study for instance 
the induced fit noted by a number of studies dating back to 1950s (Koshland, 1959; 
Yankeelov and Koshland, 1965).
The presence of the single tryptophan in shikimate kinase provides a convenient probe for 
monitoring the stmctural changes which occur on binding substiates. This information can 
be compared with that available on the homologous enzyme adenylate kinase. Examples of 
engineering tryptophans within adenylate kinase from E. coli has been shown in Bilderback 
eta l, (1996).
The elucidation of crystal structure of adenylate kinase has made it is possible to see the 
induced fit movement on an atomic level and this has been well documented in a number of 
studies (Schulz et al, 1990; Gerstain; 1993; Muller et al, 1996 and Sinev et al, 1996ab).
A movie generated from various liganded forms of adenylate kinase can be found on the 
internet;
fluorescence quenching. Alternatively the data could be analyzed by means of a double 
reciprocal plot (Lineweaver Burk plot) as shown in Fig 4.5.
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4.2.3 Methods
Substrates, shikimate, ADP and ATP (lOmM and 50mM stock solutions) were made up in 
buffer A (35mM Tris/HCl, 5mM KCl, 2.5mM MgCk, 0.4mM DTT pH 7.5) and the pH 
adjusted if necessary to pH 7.5. Shikimate kinase was dialyzed against buffer A for two 
hours and then used at a concentration of 0.2mg/ml. Titrations were canied out in a 
similar way as described in section 4.1 above using the READ mode setting on the 
specti'ofluorimeter. Substrate solutions rather than quenching agent stocks were used; 
generally 10 x lOpl aliquots of lOrnM stock solution followed by 5x lOpl aliquot additions 
of the 50mM substrate stock solution.
It was necessary to use the model compound NAT A to correct the titration data for any 
possible inner filter effects and for dilution caused by addition of ligand.
Data collected were then analysed by the program ‘Leonora’ (Comish-Bowden 1996) 
which fitted data to a hyperbolic saturation curve giving the Kd and the limiting degree of t
i!
4.2.4 Results/Discussion
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Figure 4.4 : The binding of shikimate to shikimate kinase as 
monitored by fluorescence quenching.
A typical Michaelis-Menton curve is obtained after titration 
of shikimate upon shikimate kinase.
A and B represent data obtained in the absence and presence 
of ADP (1.5mM) respectively.
1-Fo/Fn is the resulting degree of quenching when corrected for 
dilution and filter effects using the model compound NATA.
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Figure 4.5: Double reciprocal plot showing the differences in Kd values
for shikimate obtained in the absence (A) and presence (B) 
of ADP (1.5mM).
Kd values were 745pM and 320 pM respectively.
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ÀThe Kd values obtained for the binding of shikimate to shikimate kinase were similar to 
those obtained in steady state kinetics. The dissociation constant in the absence of 
nucleotide was 700 juM; this is reduced in the presence of 1.5mM ADP to 320pM which is 
comparable to the Km value obtained from an analysis of steady state kinetic data. The two 
fold increase in affinity of the enzyme for shikimate in the presence of nucleotide is 
consistent with the proposal of substrate synergism. Substrate induced structural changes 
which underlie such synergism have been well documented in a number of kinases.
Phosphoglycerate kinase has been observed to imdergo a hinge motion with a positional 
displacement of 2.7nm for the ends of the domains relative to the unliganded structure 
(Bernstein et al, 1997), complete hinge closur e for this enzyme has been brought about by 
the synergistic combination of both substrates. Adenylate kinase has been studied in much 
greater detail and detailed structures of differently liganded forms the enzyme have been 
combined together to form a movie of ligand binding (Schulz et a l, 1990; Gerstain, 1993;
Muller et al 1996; Sinev et al. 1996ab). Movement of the hinge domain within adenylate 
kinase takes place with a displacement of up to 3.0nm.
This movement, correlated with the results shown above, illustrates that where the 
tryptophan is located, between helix three and four of shikimate kinase, there must be a 
degree of flexibility. This ‘degree’ of flexibility however could only be quantitatively 
resolved by much more detailed work using actual fluorescence energy transfer 
experiments (Bilderback et a/., 1996) or the ability to crystallize a number of differently 
bound states of shikimate kinase as has been done with adenylate kinase.
Analysis of the binding of the nucleotide, ADP, to shikimate kinase proved to be more
complex.
7
I
6 7
'!■
I
It was found that the fluorescence quenching data would not fit firstly to a simple 
hyperbolic curve, and since consequently the double reciprocal (Lineweaver Burk) plot was 
not linear (Fig 4.6) the binding data could be fitted to a Hill plot (Fig 4.7a,b) from which it 
was possible to estimate a Hill coefficient.
1 /1-E
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X
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Figure 4.6: Double reciprocal plot of the fluorescence 
quenching of shikimate kinase by ATP.
Illustration that the binding is of a non-hyperbolic type.
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Figure 4.7a : Data for  the ATP quenching o f  shikimate kinase
fluorescence fitted to the Hill equation.
The parameters obtained from the fitting process were ;
23.1± 0.007% 
658±0.023|rM
Limiting value of (1-E) 
Concenti’ation at half saturation 
Hill co-efficient, h 2.66 + 0.21
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Figure 4,7b : Data for the ADP quenching of shikimate kinase
fluorescence fitted to the Hit! equation.
The parameters obtained from the fitting process were ;
52.0+0.0235% 
669+ 0.047p,M
Limiting value of (1-E) 
Concentration at half saturation 
Hill co-efficient, h 1.579 + 0.115
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The kinetic data for the apparent nucleotide binding gives a Km of 700 p,M. This is then
comparable to the data that are obtained from the Hill plot in both 4a and 4b where the
concentrations at half saturation are 658pM and 660pM for ATP and ADP respectively.
The nucleotide titiations clearly do not fit a simple hyperbolic curve and consequently the
data fitted to the Hill plot suggest some degree of co-operativity in nucleotide binding .
.The Hill co-efficient gained in each of the above mentioned cases is 2.66 for ATP and 1.58 
for ADP.
This demonstration of co-operativity indicates that there may be one or more additional 
binding sites for nucleotide in shikimate kinase. . '3
Further experiments in this chapter used isothermal titration calorimetry (ITC) as another 
means of measuiing substrate binding.
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Figure 4,8 : The biudiug of ATP to shikimate kinase (wild type)
as monitored by isothermal titration calorimetry.
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Enzyme Number of sites Dissociation 
constant (pM)
Enthalpy
(cal/mol)
E, chrysanthemi (SKII) 
wild type + ATP 0.83 24.3 2923
0.66 22.5 3422
wild type + ADP 1.12 34.8 3124
CI3S mutant + ATP 0.60 43.3 2394
Table 4.2 : Nucleotide binding to shikimate kinase type II from E* chrysanthemi
as monitored by isothermal titration calorimetry.
The ITC data shown above indicate that ATP binding is much tighter (23p,M) than is 
suggested by the apparent Km (700 pM) derived from an analysis of kinetics. The ITC 
traces appear to fit in a satisfactoiy manner to a one site model, which would conflict with 
tlie conclusion reached from the fluorescence quenching data (Fig 4.7).
Problems were encountered with shikimate titrations in ITC; when using the same initial 
concentration of shikimate (2mM stock solution). Titrations with the shikimate from this 
stock gave no reasonable binding curve. High shikimate concentrations (up to 50mM) gave 
rise to a high signal to noise ratio. Thus the values derived fiom the fluorescence 
quenching are the most useful to comment on the shikimate binding (Fig 4.4).
The two methods used give very different results for the binding of nucleotides to the 
enzyme. In principle the ITC method should give die more reliable data since it is based on 
the enthalpy changes which accompany complex formation. The values for Kd obtained by
7 3
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ITC are significantly lower than either the apparent Km from analysis of steady state 
kinetics or the concentration range over which fluorescence is observed. Since addition of 
nucleotides leads to trivial quenching of protein fluorescence by an inner filter effect (Price, 
1972), it is necessary to correct for this by performing parallel titrations of the model 
compound, NATA, with the nucleotide. When these corrections have been carried out the 
actual degree of quenching of shikimate kinase fluorescence is quite small, up to about 
23%, Figure 4.7a. Although this type of method has been used successfully to analyse the 
binding of nucleotides to various kinases (Price, 1972) it is possible that the method may 
not be appropriate in the case of shikimate kinase. To investigate this possibility titrations 
should be performed with proteins such as lysozyme or bovine serum albumin which do not 
bind nucleotides. Shikimate kinase may indeed possess two binding sites for nucleotides, a 
high affinity site which does not lead to fluorescence quenching but which can be detected 
by ITC and a low affinity site, binding which is accompanied by a small enthalpy change 
but by significant fluorescence quenching. Final resolution of the situation will only be 
possible when the binding is analyzed by a direct binding method such as equilibrium 
dialysis.
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Chapter 5 : Chemical and thermal dénaturation of shikimate kinase type II
from Erwinia chrysanthemi.
5.1 Abstract
The unfolding of shikimate kinase was studied both using both chemical (increasing 
concentrations of guanidinium chloride (GdnHCl) and thermal dénaturation. Chemical 
dénaturation was measured by the loss of secondary structure, as monitored by far UV 
Circular Dichroism (CD) and measuring the loss of tertiary structure as monitored by 
fluorescence changes.
Shikimate kinase was denatured both in the absence and presence of the substrate shikimate 
and ATP. Thermal dénaturation was observed by the use of Differential Scanning 
Calorimetry (DSC) and the effects of ligands on the stability of the enzyme were judged by 
changes in Tm and the thermodynamic parameters (AHcai and AHv’h)- Thermal dénaturation 
was also monitored by changes in the secondary structure, using far UV CD.
The concentration of GdnHCl which gave 50% dénaturation was shown to be 1.25M and 
the total loss of structure was seen at 4M GdnHCl.
Thermal stability studies showed that the general temperature of ‘unfolding’ and collapse of 
structure was seen at 39°C. This unfolding temperature was increased in the presence of 
saturating concentrations of the nucleotide substrates ATP and ADP (2mM) to 47°C. No 
dramatic increase is seen in the presence of shikimate at 2mM.
It became apparent when monitoring the chemical dénaturation in the presence of substrate 
(shikimate) by fluorescence that a two stage unfolding occuied. This was illustrated by the 
loss of shikimate binding capability between 0 and IM GdnHCl prior to the total unfolding 
of the enzyme. These observations can be interpreted as indicating that low concentrations 
of GdnHCl gave rise to small perturbations within the str ucture which lead to the disruption 
of the shikimate binding site.
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5.2 Introduction
A wide variety of biophysical techniques are used for the study of protein dénaturation 
including circular dichroism, fluorescence and differential scanning microcalorimeüy.
These have provided powerful ways to follow the characteristics of intermediates that occur 
within the protein folding pathway.
Studies on the dénaturation of adenylate kinase by GdnHCl have been undertaken (Zhang, 
et a l 1993, 1998). Dénaturation studies of proteins using DSC have also been well 
documented (Cooper et al. 1999). DSC is a very accurate way of determining the thermal 
transition and can be used to determine the absolute thermodynamic data from thermally
S'
induced transitions. The technique has been used to show how thermal stability can be 
affected by experimental conditions; for example glucose will protect glucokinase against 
both thermal and proteolytic degradation (White et al, 1990). The effect of buffer 
composition used during DSC has been investigated in particular looking at the stabilisation 
that Zn^  ^offers carboxypeptidase B (Conejero-Lara et al, 1991), and the scan rate utilised 
has been shown to affect the dénaturation of yeast phosphoglycerate kinase (Galisteo et al,
41991). The formation of enzyme ligand complex via a Schiff base which is part of the 
catalytic mechanism of dehydroquinase type I has been shown to have great effects on the
I
stability of the enzyme (Kleanthous et al, 1991). ç
The unfolding of the adenylate kinase and the shikimate kinase can be compared since both 
are monomeric kinase enzymes of similar molecular mass and with similar overall
.1
structure.
Ii
5.3 Methods
Shikimate kinase was prepared as described in Section 2.7. The enzyme was dialysed
against two changes of Buffer A (35mM Tris/HCl, 5mM KCl, 2.5mM MgCE, 0.4mM DTT
pH 7.6). Incubation in GdnHCl (made up in buffer A) was caiTied out for 1-2 hours. All
measurements were made at 20°C; for fluorescence, measurements were made using a
Perkin Elmer L550 specti'ofluorimeter in 1ml cuvettes. CD spectra were recorded on a
.JASCO J-600 spectropolarimeter using a 0.05cm pathlength cell. Fluorescence scans were
carried out on each sample using the excitation wavelength of 290nra and emission at
350nm using slit widths of 2.5nm bandpass adjusted to cater for different protein
concentrations. For each sample the wavelength of maximum emission (Imax) and the
intensity of fluorescence at 347nm were recorded. From the changes in these parameters
the % change in structure at each concentration of GdnHCl could be calculated. For the
DSC measurements the enzyme was also extensively dialysed against buffer A. Enzyme
concentration was adjusted to 1 mg/ml by the addition of dialysis buffer. Solutions of
ligands were also prepared in the dialysis buffer in order to keep the ionic strength constant.
.Data were obtained using a Microcal-MCS system (Cooper et.al, 1999) and the Microcal 
Origin package (Microcal Software Inc.) was used to analyse the data in order to determine 
the Tm and thermodynamic parameters.
::S
I
I
7 7
5.4 Results/Discussion
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Figure 5.1 iBenaturation of wild type SKII in presence of GdnHCl
illustrating tlie change in intensity and the shift in the emission 
maximum from the native to denatured states.
A; native state (CM GdnHCl), B; denatured state (5M GdnHCl). 
Spectra were recorded at 20”C in a 1cm pathlength cuvette over the wavelength 
range 300-400nm, SKII was set up at a protein concentration of 0.2mg/ml with 
increasing concenti ations of GdnHCl but for clarity only the scans for native and 
fully unfolded enzyme are shown.
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Figure 5.2 : Secondaiy structure changes during thermal
dénaturation as monitored using Circular Dichroism.
Protein concentration of 0.5mg/ml were used and CD spectra 
recorded at the temperatures indicated. Increasing concentrations of 
(GdnHCl) as with the increasing temperature above also show loss of 
secondary structure. Such degree of sti’ucture loss is monitored using 
the wavelengths of 208nm and 225nm.
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Figure 5.3 : Secondary structure dénaturation profile of shikimate
kinase
Unfolding was monitored by changes in ellipticity at 222nm 
of shikimate kinase (0.2mg/ml) in the presence of increasing 
[GdnHCI].
Squares :wild type; circles :C13S; triangles:K15M.
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The changes in the fluorescence and far UV CD of shikimate kinase on incubation with 
GdnHCI for 2 hours were monitored. In each case incubation with both 2.8M and 4.8M 
GdnHCI lead to essentially complete loss of structure as indicated by:
i) the shift of the fluorescence emission maximum from 348nm to 355nm (Fig. 5.1). The 
latter value is essentially identical to that of the model compound NAT A which has a X 
(356nm).
ii) the more than 10 fold decrease in ellipticity at 225nm. Data in Fig 5.3.
The changes illustrated in Figure 5.3 illustrate the percentage of total change in secondaiy 
structure of shikimate kinase between 0 and 6M GdnHCI. There is a small increase in the 
intensity of the ellipticity at 222nm between 0 and IM GdnHCI, giving rise to negative 
values in Fig. 5.3 in this range. This increase is not shown in the K15M mutant and 
therefore it might be concluded that the secondary structure of the K15M is somewhat more 
stable than that of the wild type enzyme. Comments regarding this stability are discussed in 
greater detail later.
The changes in fluorescence are almost superimposable on those seen in the CD, indicating
■i
an essentially identical pattern of dénaturation.
The sharp nature of the changes in CD and fluorescence between 1 and 1.3M GdnHCI 
suggest that the overall secondaiy and tertiary structures of the SK are lost in a process in 
which the entire monomer unfolds in a highly co-operative fashion.
In the presence of substrate, 2mM shikimate, the fluorescence data during dénaturation 
show an unusual biphasic behaviour (Figure 5.4).
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Figure 5.4 Dénaturation of shikimate kinase in the presence of substrates.
Fluorescence changes seen in GdnHCI dénaturation of shikimate 
kinase in the presence (circles) and absence (squares) of 2mM 
shikimate.
For ease of comparison, the fluorescence values at CM GdnHCI are 
normalised to 100. The actual value in the presence of shikimate is 
35, reflecting the quenching accompanying the binding of ligand 
(Fig 4.4).
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Thermal dénaturation provides another means to obsei^ve any possible ligand induced 
stability. Shikimate kinase was monitored by means of differential scanning calorhnetiy 
(DSC) which provides a number of thermodynamic parameters related to the protein 
stability. In the presence of ligands, both shikimate and ATP and the dead end complex 
shikimate plus ADP it was possible to measur e the degree of stabilisation provided by the 
ligands.
In the presence of substrate shikimate it can be seen that the shikimate binding domain is 
lost prior to the complete unfolding of the enzyme. This is illustrated by the 2.5 fold 
increase in fluorescence seen in Figure 5.4 corresponding to the quenching by shikimate. I
The concentration of GdnHCI which leads to the dissociation of the substrate shikimate is 
not sufficient to lead to significant loss of the overall secondary and tertiary strtrcture, since 
there are no changes in the far* UV or fluorescence in the presence of IM GdnHCI. Small 
increases in ellipticity observed at low concentrations (0.5M) of GdnHCI have been noted 
for a number of enzymes and have been interpreted as indicating that the low levels of the
dénaturant can stabilise proteins by altering the solute/solvent forces.
It is not possible to study the unfolding of protein by fluorescence in the presence of s
nucleotide since binding of nucleotide brings about a much smaller quenching of 
fluorescence. In addition the presence of nucleotide leads to a large ‘inner filter’ effect and 
so any possible dissociation of ligand would be difficult to detect.
83 !
0.0004
0.0002
0.0000
- 0.0002
o
-0.0004
-0.0006
-0.0008
- 0.0010
Siikimate Mnase+ AOP (1 rrtyi)
Kinsee+ATP (ImM)
SNkimaie Kinase+ 
Sikimste (ImM)
SNkimate Kinase' 
only
I
20 40 60
ÏOTperaîurefC)
100
Figure 5.5 ; Differential scanning calorimetry scans showing shift 
in the T,n of shiWmate kinase in the presence of the 
various ligands indicated.
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Enzyme Conditions Tm
CC)
AHcai (J/moI) AH»vh (J/mol)
wild type no ligand 39.70 737x10* 8.95 X 10*
50‘^ C/hour O.lmMATP 42.11 7.62 X 10* 9.35 X 10*
ImM ATP 48.12 9.98 X 10* 1.18x10*
lOT/hour^' no ligand 36.13 5.37 X 10* 1.04x10*
ImM ATP 45.01 7.88 X 10* 1.4x10*
C13S no ligand 39 7.62 X 10* 9.35 x 10*
ImM ATP 46.13 9.85 X 10* 1.21 X 10*
K15M no ligand 43.87 4.66 X 10* 1.49x10*
ImM ATP 45.0 5.05 X 10* 2.06 xlO*
wild type no ligand 39.65 6.72x10* 8.7 X 10*
2mM shikimate 41.75 8.04 X 10* 1.04x10*
2mM ADP 4T26 9.03 X 10* 1.17x10*
2mM ATP 49.88 9.75 X 10* 1.25x10*
2mMADP/Shi............................ 50.21 6.85 X 10* 1.81 xlO*
Table 5.1 : BSC results showing the T,„ and thermal stability of
shikimate kinase type ÏI from E. chrysanthemi
in the absence and presence of ligands.
All measurements unless otherwise indicated^' were taken with a 
scan rate of 50°C/hour. The protein concentration was 1 mg/ml.
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Figure 5.6: Thermal dénaturation profile monitored by changes in
ellipticity at 222nm.
The stability of the secondary structure was monitored in the absence 
(squares) and presence (diamonds) of O.lmM ATP and in the presence of 
ImM shikimic acid (triangles).
The maximum stability is seen in the presence of ImM ATP (circles).
In these experiments the temperatiue was increased by 10°C/hour.
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5.5 Further Discussion
The thermal dénaturation studies illustrate the effect of ligands on the values of T^ (Table 
5.1). In the absence of any ligand, the C13S and wild type enzymes show a very similar 
Tm (39®C), in the presence of ImM ATP this is increased to a Tm of 46"^ C and 48”C for 
C13S and wild type respectively. The addition of 2mM ATP, which presumably leads to 
enhanced saturation of the enzyme, increases the Tm to a value of 50°C. Shikimate 
however, does not offer the same protection since the change in Tm of wild type shikimate 
kinase increases by only 2°C in the presence of ImM shikimate. The dead end complex of 
ADP (2mM) plus shikimate (2mM) gives a Tm of 50.2rC; thus very little extra effect 
additive effect is seen when shikimate is added to the nucleotide-enzyme complex.
These data therefore show that the nucleotide offers greater stabilisation than shikimate. 
This can be understood since there are a greater number of residues involved m co­
ordinating the nucleotide compared with those required for shikimate co-ordination.
The general stability of the Cl3S mutant does not seem to be affected since values gained 
with the C13S are comparable to those seen in the wild-type. In the presence of ImM ATP 
the Tm for C13S is 2°C lower than the wild type; this may indicate that the ATP is not as 
tightly bound or, as well co-ordinated to the structure of the C13S mutant as to the wild 
type.
The most interesting results however are those seen for the K15M which show a 
significantly higher Tm (44°C) in the absence of ligand; this is increased only to 45°C in the 
presence of ImM ATP. The data indicate that the K15M mutant has intrinsically greater 
stability than the wild type enzyme. Addition of nucleotide causes only a minor increase in 
Tm which indicates that binding or co-ordination of ligand to the mutant is weaker than to 
the wild type.
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Figure 5.7 : Topology of shikimate kinase wild type and mutant K15M.
Comparison of the K15M mutant shikimate kinase (left) in the open conformation 
showing the regions which compose the active site. The overlaid wild type (pale 
colours) and K15M (dark colours) are shown on the right.
These figures were kindly provided by Dr. John Maclean (University of Glasgow, 
crystallography department, personal communication).
Figures 1.6 and 1.7 in the introduction may aid in locating the named residues.
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Figure 5.8a : Alterations in the P-loop region of shikimate kinase between 
K15M and wild type enzymes.
Note the formation of the new ion pair between Cl 3 and RllO which 
is formed in K15M but which is not seen in the wild-type. The side 
chain of R11 has been shifted into the binding site where it 
forms ion pairs with the side chains responsible for the Mg^  ^binding 
in the wild type, that is D32 and T16. The R ll is also involved in 
coordinating the phosphate which is located in the active site within 
the K15M mutant
89
C M
P O
V l
# .
K l l
Figure 5.8b : Electron density around the P-loop in the K15M mutant.
The map shows the new ion pairs seen in the K15M mutant, 
(those between C13 and RllO, and between the side chains 
of R ll and D32 and T16), which are not present in the wild 
type enzyme.
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The new ion pairs formed in the K15M mutant may be the reason for the elevated Tm of this 
enzyme compared with that of wild type, since these ion pairs are known to have greater 
stability than is observed on co-ordination of alone (Barlow and Thornton 1983).
The presence of the ion pairs explain why no enhancement of ellipticity is observed at low 
concentrations of GdnHCI in the K15M mutant compared with the wild type (Fig 5.3).
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Chapter 6 : Refolding Of Shikimate Kinase type II from Erwinia chrysanthemi
6.1 Abstract
The refolding of shikimate kinase was initiated by dilution of enzyme solutions in the 
presence of the dénaturant guanidinium hydrochloride (GdnHCI). The refolding upon the
dilution of GdnHCI from both 4.8M to 0.44M and from 2.8M to 0.25M GdnHCI was 
monitored using circular dichroism (CD) and tryptophan fluorescence. Both manual 
mixing and stopped-flow methods were carried out to record the time courses of changes of 
secondary and tertiary structure respectively. Rapid regain of secondary structure took 
place with almost 100% of the total change happening within the dead time of the manual 
mixing procedur e (15 sec). Using stopped-flow mixing it was possible to detect some of the 
final stages of the regain of secondary structure but even so 60% of the secondary structure 
was formed in the dead time (8msec).
Manual mixing using fluorescence showed 60% of the total fluorescence regained during 
the dead time (15sec) however stopped-flow techniques allowed the initial stages of 
fluorescence changes to be monitored. A bi-phasic curve was obtained indicating very 
rapid initial folding accounting for 10% of the total change followed by a slower process 
with rate constants of 0.006 and 0.24 sec respectively.
In the presence of ANS however there was interference with the regain of native structure 
and during refolding on the manual mixing time scale, aggregation was seen illustrating 
incorrect folding for at least a fraction of the enzyme present.
There was a dramatic increase in ANS fluorescence during refolding of shikimate kinase
compared with that obsei*ved in the initial (2.8M) or final (0.25M) concentrations of
GdnHCI. During refolding ANS apparently binds strongly to hydrophobic residues
exposed in an intermediate. Once complexed with ANS this intermediate is not able to
refold correctly and release the ANS, but would appear to be prone to aggregate formation.
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6.2 Introduction
The study of protein folding generally involves tiying to understand the process by which a 
fully unfolded protein (U) matures into the folded native protein (N) and identifying any 
intermediates that may lie between the two states (Bycroft et <3/ .,  1990; Creighton, 1990,
I
1996; Radford et al, 1992). Protein folding has been proposed to occur via transient 
partially ordered intermediates. In many proteins these intermediates have been classified 
as being of the ‘molten globule’ type. This is a state where the protein is reasonably 
compact and has native or near to native secondary structure but non-native fluctuating 
tertiary structure. The molten globule is postulated as an important intermediate in the 
protein folding pathway (Ohgushi and Wada, 1983) and is thought to appear early in the 
folding process of many proteins as a results of a rapid hydrophobic collapse of the 
polypeptide chain (Jones et al, 1995).
The refolding pathway when studied on a very small time scale such as stopped-flow is able 
to elucidate the initial stages of protein structure formation which still remain a major 
unsolved area of modem stmctural biology (Kim and Baldwin, 1990).
Steady state refolding studies in proteins invariably show very rapidly formed 
intermediates. Secondaiy structure and indeed some enzyme activity are often formed 
within the dead time of manual mixing and so it is necessary to use stopped flow CD, 
(Kuwajimi et al, 1987 and 1996; Price et al, 1999) and fluorescence (Engelhard and 
Evans 1996) to observe the rapidly formed intermediates.
Such studies have been undertaken to map out the folding pathway of shikimate kinase and 
to identify some of the rapidly intermediates involved.
The reagent ANS (8-anilino-l-naphthalene sulphonate) is a commonly used probe for the 
molten globule state of proteins (Ptitsyn, 1990; Semisotov et a/., 1991). ANS binds 
extensively to the hydrophobic sites of the molten globule; as the tertiary structure becomes
9 3
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more native-like these sites disappear and ANS is released. Accordingly the increase and 
decay of ANS fluorescence has been used as a probe for the transient molten globule state 
during protein folding (Ptitsyn, 1995).
Apart from its intrinsic scientific interest and commercial importance, such as the
development of methods for recovery of expressed proteins from inclusion bodies,
understanding protein folding will shed light on many defective diseases which are lonown
to occur due to incorrect protein folding and processing. Human genetic diseases can be 
.due to mutations in proteins which influence their trafficking and lead to retaining of
protein in the endoplasmic reticulum or incorrect processing (Bychova, 1995). One of the 
.most common genetic diseases in humans is cystic fibrosis (CF). The membrane
9 4
associated, N-linked glycoprotein (CFTR) is incorrectly folded due to lack of full 
glycosylation (Cheng et al, 1990; Denning et al, 1992) this leads to failure of an epithelial 
cell chloride channel to respond to cAMP thus leading to cystic fibrosis.
A review of defective protein folding as a basis of human disease is found in Thomas et al, 
(1995). Misfolding and indeed the ability to form very stable structure due to the 
misfolding has been shown to cause the pathogenicity of scapie, with the infectivity due to 
stmctural changes in the prion protein (Gasset et a/., 1993,). A similar situation occurs in 
the bovine spongiform encephalopathy epidemic (Purdey, 1996a,b; Lasmezas et al, 1997; 
Hope et (3/., 1999).
Formation of amyloid plaques in Alzheimer’s disease may be a consequence of a 
conformational transition from the largely a-helix native state to a jJ-sheet structure in the 
amino tenninal region of the amyloid p-peptide (Soto et a l, 1995; Crawford et. <3/ . , 1998).
î
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6.3 Methods
GdnHCI was made up as an 8M stock solution in buffer A (35mM Tris/HCl, 5mM KCl, 
2.5mM MgCli and 0.4mM DTT, pH 7.5). ANS was also made as a ImM stock solution in 
buffer A and stored in the dark. Both solutions were made up fresh.
Protein was dialysed as standard for at least two hours into buffer A and stock 
concentrations made up as required mostly from 1 mg/ml in the denaturing solution prior to 
refolding.
Refolding was initiated by an 11 fold dilution reducing the concentration of GdnHCI from 
2.8M to 0.25M. This was monitored in both a steady state fluorimeter and the stopped-flow 
apparatus using the appropriate wavelengths for protein fluorescence at (excitation 290nm; 
emission 350nm) and ANS fluorescence (excitation 380nm; emission 480nm).
Both steady state and stopped-flow results over varying time courses are shown.
The values regarding rates of refolding during tertiary and secondary structure regain with 
reference to denatured and refolded enzymes are also given.
9 5
«6.4 Results/Discussion
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Figure 6,1:
Hub (sec)
The refolding of shikimute kinase as monitored by 
protein fluorescence
Shikimate kinase 0.09mg/ml (C) was monitored at 350nm 
after dilution from 4.8M-0.44M GdnHCI. A dead time of 10 
seconds occurred prior to recording data points.
(A) Native state shikimate kinase in 0.44M GdnHCI
(B) Denatured state shikimate kinase in 4.8M GdnHCI
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Figure 6.2: The refolding of shikimate kinase as monitored by
stopped-flow protein fluorescence.
Shikimate kinase 0.09mg/ml (C) was monitored at 350mn after 
dilution from 2.8M-0.25M GdnHCI. There is only l-3msecond 
of dead time when using the stopped flow apparatus.
(A) Native state shikimate kinase in 0.25M GdnHCI
(B) Denatured state shikimate kinase in 2.8M GdnHCI.
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Figure 6.3: The refolding of shikimate kinase as monitored by
stopped-flow CD.
Shikimate kinase 0.09mg/ml (C) was monitored at 230nra 
after dilution from 2.8M-0.25M GdnHCI.
(A) Denatured state shikimate kinase in 2.8M GdnHCI
(B) Native state shikimate kinase in 0.25M GdnHCI
(C) Refolding enzyme diluted from 2.8-0.25M GdnHCI.
Fitting the data shown in C to a first order process gave a first order rate 
constant of 0.125 sec"\ The change occuiTing in the dead time accounts for 
60% of the total structural structure again.
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Enzyme
E, chrysanthemi (SKIÏ)
Regain % of total
wild type (no ligands) 
w.t+ATP (ImM) 
w.t.+shikimate (ImM)
CD Fluorescence Activity
97.2 + 3.8 95 + 2.3 83 + 4.2
87.3 + 6.0 81 + 5.4 75 + 6.3 
97.9 + 4.1 85 + 3.9 80 + 3.8
Table 6.1: Regain of CD (secondary structure), fluorescence (tertiary
structure) and activity of shikimate kinase 30 minutes after 
refolding had been initiated by mixing.
Enzyme ki Amplitude of k2 Amplitude of
Cone. (sec' )^ first phase (%) (sec‘^ ) slow phase (%)
0.045mg/ml* 0.062 49.4 0.0074 50.6
0.067 52.4 0.0085 47.6
0.09mg/ml* 0.042 6L8 0.0077 38.2
0.038 60.5 0.0067 39.5
0.09mg/ml ** 0J35 62.3 0.0063 37.7
Table 6.2: Values of the actual rates and amplitudes of the fluorescence
changes on refolding of shikimate kinase following dilution of
GdnHCI from 4.8M to 0.44M* and 2.8M to 0.25M** dilution.
** Concentration of GdnHCI (2.8M-0.25M). The regain of 
tertiary structure is four tunes faster for the initial stage of 
refolding indicated by the rate constant being 0.235 sec"\
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Figure 6.4: Changes in ANS fluorescence during refolding of shikimate 
kinase in stopped flow apparatus.
Shikimate kinase (0.09mg/ml) was refolded in the presence of ANS 
(40pM). ANS fluorescence monitored at 480mn (excitation 380mn).
(A) Native enzyme 0.25M GdnHCI +ANS (40pM)
(B) Denatured enzyme 2.8M GdnHCI +ANS (40pM)
k (rate constant obtained from data after 2.5 seconds) = 0.264sec"^
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6.5 Further Discussion
6.5.1 Dénaturation ■i
Incubation at 20^C at concentrations of 2.8 M GdnHCI or greater is required to bring about 
complete unfolding of shikimate kinase as indicated by changes in fluorescence (See chapter 
4). In practice, a 2 hour incubation in GdnHCI (2.8M and 4.8M) was used out to bring about 
total dénaturation prior to the initiation of refolding. Refolding was initiated by dilution of 
the denatured enzyme with 10 volumes of buffer both in manual and stopped flow mixing 
methods thus reducing the final concentration of GdnHCI to 0.44M and 0.25M respectively.
It should be noted that the greatest degiee of dilution obtainable in the stopped-flow 
apparatus was 11 fold.
'S
6.5.2 Changes in fluorescence during regain of structure
The refolding of shikimate kinase via the regain of tertiary structure as monitored by 
fluorescence reveals more of the early stages of tertiary shucture acquisition.
A biphasic curve results which is in common with other studies where a fast and then slower 
process for fluorescence regain has been observed (Semisotov et al, 1991; Elove et al,
1992). Refolding of shikimate kinase however gave a biphasic process with rate constants of 
ki 0.24 and k.2 0.007 sec'  ^for the faster and slower phases respectively.
The activity was also monitored during refolding and 80% activity was recovered after 5 
minutes. Due to the nature of the assay it was not possible to study activity recovery on a 
shorter time scale.
It would have been interesting to have monitored the fluorescence changes over a shorter 
time period but when the increment of time at which readings are taken is reduced to less that 
10msec then there is a greater signal to noise ratio which makes interpretation more difficult.
10 1
multimeric protein dehydroquinase (Price et al, 1999) where the slow phase of the CD 
changes has a rate constant of 0.07sec'\ The final refolded structure appears to have 91% 
total regain of structure.
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The speed at which regain of secondary structure has occurred during refolding has been well 
documented in the bui'st phase stages of the refolding of lactoglobulin (Kuwajimi, 1996).
6.5.3 Changes in CD during refolding
It was found using manual mixing teclmiques and monitoring the secondary structure regain 
by following the ellipticity at 225nm that refolding of shikimate kinase at a concentration of 
50pg/ml occurred largely in the dead time of mixing (about 10 -15seconds), with no further 
changes observed (data not shown). The CD spectrum of enzyme after 15 minutes refolding 
was very similar in shape to the spectrum obtained from a control enzyme sample which had 
not been subject to the cycle of dénaturation and refolding.
By using stopped-flow mixing it was possible to monitor the formation of secondary structure
and show that it was a fast process which when monitored at 230nm, showed that 62% of the
secondaiy structure was formed in the dead time (8msec). This result is comparable to a
number of systems studied in this fashion where a large proportion of the secondary structure
is regained within the dead time of the stopped-flow apparatus. In cytochrome c 44% of the
structure is regained (Elove et aL, 1992) and the refolding of P-lactoglobulin also shows a
very rapid regain of secondaiy structure (Kuwajima et a/., 1987, 1996; Aral et a/., 1998).
From such studies it can be said that the veiy rapid regain of the secondaiy structure is a
common feature in the folding of globular proteins. However, there is a some what slower
process of regain which complements the data gained in the biphasic curve of fluorescence 
.regain, this remainder of the secondary structure was regained in a process that can be fitted
,to a rate order constant of 0.125 sec . Such a biphasic process has also been seen in the
1 0 3
The results above illustrate the limitations of conventional rapid mixing techniques to study 
the refolding of such a small monomeric protein as shikimate kinase. Thus in trying to 
identify any intermediates that may exist hydrophobic fluorescence molecules such as ANS 
can provide valuable information.
6.5.4 Changes in ANS fluorescence during refolding
The refolding of shikimate kinase shows a somewhat different pattern when the experiment is 
conducted in the presence of ANS. There was a 20 fold increase of ANS fluorescence 
during refolding; however the ANS fluorescence does not show any subsequent decline as 
has been found during the refolding of a number of other proteins.
The initial binding of ANS does not seem to take place very quickly upon refolding as there 
is a Tag" phase which lasts for about 2 seconds from the start of refolding. Following this 
there is a much enhanced binding of the ANS which gives rise to the 20 fold increase in 
fluorescence. The increase seems to reach a plateau after about 10 seconds. Comparing the 
extent of regain of activity of wild type enzyme in the absence and presence of ANS we can 
see that there is a significant discrepancy between the values obtained. 80% of the activity is 
regained in the refolding of shikimate kinase in the absence of ANS, with only 60% regained 
in the presence of ANS. The 20% of mis-folded protein could account for the enhanced 
binding of ANS seen in Fig 6.4. It would be necessary to study the extent of refolding in the 
presence and absence of ANS over a range of protein concenti ations in order to substantiate 
this proposal.
«
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Chapter 7: General Discussion
7.1 Structural studies - Ligand binding
The single tryptophan residue (W54) that exists within shikimate kinase type II of Erwinia 
chrysanthemi was a useful indicator of structural changes which make up the most part of 
this study. These changes in the enzyme structure were induced upon ligand binding and 
thr ough chemical and thermal dénaturation and monitored through CD spectr'oscopy and 
fluorescence measurements.
Sequential changes in substrate binding were seen during titrations with shikimate in the 
absence and presence of nucleotide (chapter 4). The reduction in the dissociation constant 
fr om 700 pM to 320pM in the absence and presence of nucleotide respectively illustrates a 
two fold increase m affinity of the enzyme for shikimate which is consistent with the 
proposal of substrate synergism. The changes observed during ligand binding have been
shown during the study of the enzyme phosphoglycerate kinase using three dimensional 
data obtained from crystallographic studies. Ligand binding caused the enzyme to undergo 
a degree of hinge motion with a positional displacement of 2.7mn for the ends of the 
domains relative to the unliganded structure (Bernstein et al, 1997). Complete hinge 
closure for this enzyme has been brought about by the synergistic combination of both 
substrates and further evidence for the importance of a proline residue involved in the 
hinge movement has been illustrated in McHarg et al, (1999).
Perhaps though, the most investigated kinase of all has been adenylate kinase. A number 
of different structures in various liganded states have been observed through 
crystallographic analysis (Schulz et al, 1990; Gerstain et al, 1993; Muller et al, 1996; 
Sinev et al, 1996) giving detailed information as to the key residues required for substrate 
binding and indeed catalysis.
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This study of shikimate kinase illustrated a tightening of the enzyme structure as observed 
by monitoring the tryptophan using fluorescence quenching experiments. Full 
crystallographic evidence for such liganded states was beyond the scope of this study but 
certainly in the future it may be interesting to compare these with those that already exist 
with adenylate kinase.
Future work to observe the actual ‘degree’ of flexibility however could only be 
quantitatively resolved by much more detailed work using actual fluorescence energy 
transfer experiments (Bilderback et a/., 1996) or as has been mentioned the ability to 
crystallize a number of differently bound states of shikimate kinase.
7.2 Stability studies
The strength of ligand binding and the effect of that the ‘tightened’ structure had on 
stability during dénaturation was investigated in depth using a number of techniques. Both 
chemical and thermal stability gave interesting results from wild type and mutant SK II 
enzymes.
7.2.1 Chemical dénaturation
A very co-operative unfolding of the secondary and tertiary structure was found during 
chemical dénaturation (Fig. 5.3) with GdnHCl. This profile was not unlike that of the
,
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unfolding of adenylate kinase (Zhang et al, 1998) yet the mid-point of dénaturation was
somewhat elevated from the 0.7M GdnHCl found with adenylate kinase to that of 1.3M 
with the shikimate kinase and thus indicates that the SKII is more stable than the adenylate 
kinase mentioned.
i
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In the presence of shikimate during dénaturation the increase in fluorescence between 0.25-
■ 1
l.OM GdnHCl (Fig. 5.4) is indicative of the loss of the shikimate binding site prior to the 
co-operative loss of structure.
There seems to be no obvious difference in the wt, C13S and C162S mutant during 
chemical dénaturation but the K15M showed some indication of stabilization in the lower
"I
(0 to IM) GdnHCl concentrations. This stability was indeed true when theimal 
dénaturation was investigated using differential scanning microcalorimetry.
Although there seemed to be no obvious difference in the secondary and tertiary structure
u;-
loss in shikimate kinase other studies do illustrate a difference upon GdnHCl dénaturation 
(Tsou et al 1983, 1986, Uversky and Ptitsyn, 1994; Zhang et al, 1993, 1998). This is
;generally found when larger protein structures containing dimers and trimers, as single and 
mulitiple active structures combined, exist.
■■S
7.2.2 Thermal dénaturation
The greatest stabilization during thermal dénaturation is seen in the wild type shikimate 
kinase in the presence of both substrate and product mix (shikimate and ADP). An 11 
degree change from a Tm of 39°C (no ligand) to that of 50.21°C in the presence of 
shikimate (2mM) and ADP (2mM) (Table 5.1).
Such stabilization tlnough ligand binding has been investigated in the enzyme 
dehydroquinase type I. Binding of ligand to this enzyme formed a Schliff base which 
increased the Tm to a great extent from 51°C wild type unbound to 96°C with the covalently 
bound ligand (Kleanthous et al, 1991). Although this is much more elevated than that 
seen in the shikimate kinase it give further evidence for significant ligand induced 
stabilization.
a
;
IThe use of DSC has been well documented in many other examples which can be found in 
Cooper (1999).
Studies on the mutants in particular the K15M mutant were very interesting both from the 
aspect of stabilization and with the progress made on the ciystallization front (Dr. John 
Maclean personal commimication). Evidence for the existence of a second ion pair is the 
reason that we have given for the elevated Tm seen with the K15M which is only 
marginally increased in the presence of saturating concentrations of nucleotide.
Structural stability as has been suggested by Fry et. al (1986) states that lysine residues are 
suggested to have the function of enabling conformational changes to take place; thus 
removal of the lysine may have reduced all important flexibility of the structure associated 
with ligand binding and catalysis. ?
7.3 Refolding
The pattern of refolding as seen in chapter 6 has been studied in some depth.
Concenhations of 2,8 M GdnHCl or greater is required to bring about complete unfolding 
of shikimate kinase as indicated by changes in fluorescence from which refolding was 
initiated.
A biphasic cuiwe results which is in common with other studies where a fast and then 
slower process for fluorescence regain has been obseiwed (Semisotov et al, 1991; Elove et 
al, 1992). Refolding of shikimate kinase however gave a biphasic process with rate 
constants of ki 0.24 and k] 0.007 sec^  ^for the faster and slower phases respectively. 
Stopped-flow mixing was the only way in which to monitor the rapid regain of secondaiy 
structure and even so when monitored at 230nm, 62% of the secondary structure was 
formed in the dead time (8 msec). This result however, is comparable to a number of 
systems studied in this fashion where a large proportion of the secondary structure is
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regained within the dead time of the stopped-flow apparatus. This veiy rapid regain of the 
secondary structure is a common feature in the folding of globular' proteins.
The refolding of shikimate kinase shows a somewhat different pattern when the experiment 
is conducted in the presence of ANS. A 20 fold increase of ANS fluorescence during 
refolding was seen which did not show any subsequent decline as has been found during 
the refolding of a number of other proteins. Thus it was assumed, and indeed seen, that 
some aggregation was occurring that led to the partial mis-folding m the presence of ANS.
In order to investigate these Endings further experiments with varying ANS and protein 
concentrations would need to be followed monitoring using the stopped-flow apparatus.
Ij
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Appendix 1 : Investigating the importance of glycosyïation of the enzyme Candida 
rugosa by site directed mutagenesis.
(This appendix consists of the work that was carried out within Universita’ degli 
studi di Milano, dipartimento di fisiologia e biochimica, Italy over a four month 
period March-July 1998 under the supervision of Dr. M. Lotti).
A.l Abstract
This project seeks to illustrate the role that glycosyïation plays within Lipase 1 enzyme of 
Candida rugosa. It covers the strategy that was employed in order to generate site directed 
mutants, the amplification of the gene within Escherichia coli and describes some 
preliminary results on the activity of the mutants when expressed in Pichia pas tor is.
The growing interest in the organic synthesis field regarding the reaction catalysed by 
lipases, namely the hydrolysis of esters of glycerol, has arisen due to the great number of 
enantiomerically pure and optically active compounds that can be produced. This has 
stimulated detailed investigation of the mechanism of lipase catalysed reactions and factors 
determining their stereoselectivity (Boland et a l, 1991; Dordick, 1992).
Glycosyïation may play a role in the subshate selectivity or in the stabilisation of the 
protein. This study seeks to investigate the role that glycosyïation plays in the mechanism 
of lipases.
Prior to site directed mutagenesis the lipase enzyme from Candida rugosa had to undergo a 
total synthesis due to the presence of non-universal codon usage for serine (Brocca et al 
1997). The synthetic gene was then manipulated at the three sites of glycosyïation; 
asparagine 291, 314 and 351.
Expression of the various mutant enzymes was achieved after subcloning the plasmids in E. 
coli, the order of activity was found to be N291Q>N314Q>N351Q.
I
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A.2 Introduction
Lipases catalyse the hydrolysis of esters of glycerol. These enzymes exist across the 
phylogenetic tree from bacterial to mammalian species and the basic reaction is shown 
below.
JOH
-OH +3 HO_J
Glycerol Fatty acidTriacylglycerol
Figure A.2.1: Reaction of the Lipase enzyme. Adapted from Schrag et al.  ^ 1991.
The activity of the lipases can be seen to utilise a catalytic triad similar to that of the well 
known protease family (Schrag Qt al, 1991). In C. rugosa the active site serine (Ser 209) 
exists within the sequence Gly-X-Ser-X-Gly and is located in a unique supersecondaiy 
structure at a tight bend between a |3-strand and a-helix buried within the structure (Cygler 
et ai, 1992). Comparison of the secondary stincture elements of lipases have revealed a 
particular hydroylase fold (Ollis et al, 1992) as well as a lid domain consisting of one or 
two loops which regulate access of substrate to the active site.
Regulation of substrate access is the molecular basis by which stereoselectivity of 
substiates is achieved. This is termed 'interfacial activation’ a mechanism in which the 
presence of a lipid interface allows the lid domain to open and activate the enzyme. The 
stabilisation of the open form of the lid domain has been observed in the thiee dimensional
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ciystal structure of the enzyme (Grochulski et al. 1994).
The kinetics of lipases can not be analysed using the standard Michaelis-Menten equations. 
This is due to the fact that it is necessary to take into account the kinetics of adsoiption of 
the enzyme onto the lipid interface which leads to activation of the enzyme; this has been 
described by Jaeger et al. (1994). A new model for explaining the observed kinetics of the 
enzyme is shown in Fig 7.2.
1
a
c.i:
Figure A.2.2; New Model for studying lipase kinetics (Jaeger et al. 1994).
A and V indicate the external and internal environment respectively, of the lipid interface.
There are two steps to describe the kinetics of catalysis by lipolytic enzymes;
1) the physical adsorption of the enzyme at the lipid interface could include activation of the 
enzyme (Brzozowski et al, 1991; Van Tilbergh et al, 1993),
2) the formation of the enzyme/substrate complex which can be hydrolysed to give the product 
and regenerate the adsorbed enzyme.
These are represented above with the rate constants for such adsorption (kj) and dissociation (kp).
Lipases have been used traditionally in the flavour development of some foods such as 
Italian hard cheese (Steads, 1986). Now, with the advance of recombinant DNA
11 1
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technology, it is possible to investigate the use of lipases in many other applications 
including the manufacture of detergents containing an extracellular lipase, and hydrolysis
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ft • • I 'ÿ"of lower quality oils and fats to generate more highly refined lipids. Lipases can also be 
used to generate the building blocks for the production, for example of pesticides and the |
synthesis of various chiral drugs such as a-blockers. In fact, 25% of current methods 
employed for preparing chiral chemical compounds use lipases as biocatalysts (Sinisterra,
1996). Another area of interest concerns the targeting of these enzymes in pathogenic 
bacteria and fungi which are known to produce extiacellular lipases as virulence factors 
(Jaeger «/., 1994).
A.2.1 Candida rugosa and the total synthesis of the synthetic gene Lipl,
Candida rugosa is a hemiascomycetous fungus which is a good producer of lipases which 
exhibit high activity in hydrolysis and synthesis.
The secreted lipase enzymes from C  rugosa exist as a mixture of five isoenzymes encoded *
a
on different genes. Of these, Lipl protein, is the most prominent (Lotti et al, 1993). These 
genes however could not be expressed in a standard expression system such as S. cerevisiae 
due to the fact that C  rugosa utilises an unusual codon first described by Kawaguchi et al., A
(1989), The codon CUG which, universally encodes a leucine, in C. rugosa encodes a
serine, in fact, up to 40% of the serines are encoded in this way (Lotti et al., 1993)
T
including the active site serine and thus protein generated in standard expression systems is |
inactive and not secreted (Fusetti et al., 1996).
Preliminary mutations attempting to replace 50% of the CUG triplets restoring the serines 
also resulted in the lipase being inactive (Brocca, et al, 1998) and thus a full scale 
synthesis of the gene was carried out generating fully functional lipase with all the CUG 
triplets encoding a serine.
The synthetic gene was optimised for expression in the Pichia host since this host is 
becoming an increasingly attractive host for production of proteins on an industrial scale 
(Tschopp et al., 1987). The genetic manipulations were carried out on this synthetic gene.
A.2.2 Glycosylation/Mutagenesis strategy
Candida rugosa Lipl is a glycosylated protein with the sugar content accounting for up to 
5% of the total mass (60kDa) of the protein.
The post-translational modification of glycosyïation is seen in many proteins formed by a 
O- or N-glycosidic bond to the R-group of serine/threonine or an asparagine side chain 
respectively. The role of the sugar moiety could be crucial in processes such as protein 
folding, oligomer assembly, secretion or catalysis. However, although the mechanisms of 
glycosyïation are known, the functional consequences of the sugar moiety are poorly 
understood. The glycosyïation sites within the Lipl enzyme have been identified in the 
sequence (Longhi et a l ,1992) and in the recent three dimensional crystal structure 
(Grochulski et al., 1994) to occur on the asparagines (Asn) 291, 314 and 351 which all lie 
within the consenus sequence of Asn-X-Ser/Thr.
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Figure A.2.3: The Crystal Structure of Lip 1 from C. rugosa
Asn residues (red) are shown with attached sugars (white).
The lid domain is shown in yellow. In particular the Asn 351 N-acetylglucosamine (NAG) 
is thought to have some interaction with the stabilisation of the lid domain when the lipase 
is in the active (open) confirmation and it is the effect of removal of the sugars that is 
investigated in this project.
114
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A.3 Procedure.
A 3.1 Site directed mutagenesis
Site directed mutagenesis is a useful tool for probing the importance of particular residues 
within a protein structure. In this case, however, a mutagenesis strategy was employed to 
generate null mutants of glycosyïation; accordingly the most ‘silent’ of mutations was to be 
made. It was decided that the substitution of the asparagine with glutamine (Asn->Gln) 
was the most silent as all hydrogen bonds were retained. The function of the human insulin 
receptor in the p-subunit have been investigated in a similar way by mutation of each of the 
four N-glycosylated sites with the substitution of Asn by Gin (Leconte et a l, 1994).
A two stage PCR reaction requiring two complementary mutant oligonucleotides for each 
mutation. The oligonucleotides were ordered from M-Medical (Florence).
Primer Sequence Length
E.Forward 5’41I GTGGATCTTTGGTGGTGG 3’ 18-mer
E.Reverse  ^? 1470 GAAAGCGTTGTTGTAGATCAAG 3’ 22-mer
Q291F. g,911 CTTGGAAGACGCGACTCAGAACACCCCTGG 3’ 31 -met
Q291R. c,94l CCAGGGGTGTTCTGAGTCGCGTCTTCCAAAG 3’ 31-mer
Q314F. r,984 CCAGACGGTGTTCAAATCACCGACGAC 3’ 27-mer
Q314R. 5,1111 GTCGTCGGTGATTTGAACACCGTCTGG 3’ 27-mer
Q351F. 5,1097 CTTCTTCTTTGCAAGTTACCACTGATGCCC 3 ’ 30-mer
Q351R. 5,1126 GGGCATCAGTGGTAACTTGCAAAGAAGAAG 3’ 30-mer
Figure A.4: Oligonucleotide primers designed for site-directed mutagenesis of Upl
gene from C  rugosa.
Site directed substitutions occurred within the underlined codon.
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The template for the mutagenesis was the shuttle vector pPICZaB plasmid available from 
Invitrogen which has the antibiotic resistance gene for Zeocin allowing for selection of 
positive transfoimants.
The gene lipl was inserted into the vector so as to be under the strong control of the AOXl 
promoter allowing for the induced expression of lipase in the presence of methanol.
The mutagenesis was carried out using pfu DNA polymerase in order to give greater 
fidelity. The standard reaction conditions were: SOpmol of each primer and 0.3pg-0.5p,g 
DNA template in lOOpl total volume. The reaction followed a two stage PCR reaction 
firstly in the production of two fragments containing the mutation in a selected region of 
DNA and secondly the PCR reaction to generate the full length insert.
The PCR cycle involved an initial dénaturation of 94*^ C for three minutes and followed by 
twenty five cycles of 94®C, 55“C, and 72°C each for one minute with a final extension of 
72T.
411 Xhol Hinfl Hpal Acll EcoRl 14704r ■I' '4' 4^ 4/
291 314 351
Asn residues 
Figure A.S : Full length PCR product.
This shows the positions of the Asn residues and restriction sites utilised in a) ligation into 
vector (Xho 1, EcoRl) and b) in the diagnostic digests (Hinfl, Hpa I and Acl I).
Re-ligation of the insert into the plasmid was achieved using the unique Xhol and EcoRl 
restriction sites. Standard ligation conditions were used and the product formed was used 
to transform E. coli strain JMIOI. These transformed cells were grown on low salt LB
116
containing the antibiotic zeocin (25|ig/ml). Positive colonies were selected and mutations 
confirmed through diagnostic digests and analysis of products. The sequence was verified 
by DNA sequencing carried out by M-Medical.
Transformation of Pichia pastoris strain X-33 was achieved with the bicine method and 
electroporation (Becker and Guarente 1991). The freshly transformed cells were firstly 
plated out onto solid medium (YPD). Secondly, positive colonies were transfened onto 
minimal tributyrin-methanol plates and expression of the lipase was induced by methanol. 
Plates were incubated at 30°C for 48 hours.
Positive colonies secreted lipase which could be identified by the presence of a clear halo 
around the colony compared with the opaque tributyrin medium (Figure 7.7).
A fom' day induced expression of lipase was canied out in order to correlate the activity of 
the lipase with the actual amount of enzyme present within both supernatant and cell extract 
samples.
The selected colony was grown initially in a 5ml overnight (YPDS) culture. This culture 
was then used to inoculate a 30ml BMGY medium which would support growth for a four 
day expression. Induction of growth was carried out using methanol when the culture had 
reached an ODeoo of 12. Methanol was added daily (250 pi) and the medium was 
supplemented daily with a concentrated (5x) nutrient YP medium (4ml).
Samples for analysis on SDS-PAGE were prepared from both the supernatant and the cell 
extract. The cells from 1ml aliquot were centrifuged at 3,000 rpm for 5 minutes. The 
supernatant was taken from the cell pellet and protein concentration estimated. The 
remaining cells were then solubilised in the presence of sterile silica beads in ice-cold 
extraction buffer (Tavare et al, 1988), Re-centrifugation occurred to sediment the silica 
beads and the remaining cell extract sample used.
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Aliquots of the two samples, supernatant and cell extract, from each mutant were run on an 
SDS-PAGE (not shown) and transfened electrophoreticaily onto Amersham Hybond-ECL 
nitrocellulose membrane. Immuno-blotting (Fig A.6a and A.6 b) using a raised primary 
anti-body against the lipl and secondary anti-IgG was carried out as in Brocca et al. (1998). 
It can been seen (Fig. A.6 a and b) that there is production of lipase enzyme both secreted 
and within the cell extracts although the results show variations between the samples.
A.4 Results/Discussion
A
1 2 3 4 5 6 7 8
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Figure A.6a: Secreted lipase 1 enzyme from P, pastoris as detected by Western 
blotting.
The supernatants, from the transfoimed P. pastoris containing one of each 
of the lipase enzymes, were prepared after a four day induced expression; 
Lane 1: Wt (com.), 2: Wt (syn.), 3: Q291, 4: Q314, 5: Q351,
6: Double mutant Q314+Q351, 7: Triple Mutant Q291+Q314+Q351 
8: Wt (com).
The supernatants (A) from both wild type (commercial and synthetic) and mutant Q291 are 
all seen to have migrated to the same extent indicating that there are identical in size. The 
results are consistent in that the wild type and Q291 are present to a similar extent when
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compared against each other, yet these are both present to a greater extent than that seen in 
the mutants Q314 and Q351. The gel shows that the Q314 and Q351 proteins are migrating 
further than those of the wild type and Q291. This is expected as the reduction in mass 
seen with the loss of sugar moieties due to the inability to become glycosylated has caused 
them to migrate further.
There seems to be no secretion of the double or triple mutant (Lane 6 and 7); this could 
suggest that the lipase enzyme has not been secreted and thus that the sugar groups might 
contribute to translocation of the protein.
B
. *
Figure A.6b: Cell extract samples containing the lipase 1 enzyme from P. pastoris as 
detected by Western blotting.
The cell extracts from the transformed P. pastoris containing one of each of 
the lipase enzymes, were prepared after a four day induced expression;
Lane 1: Wt (com.), 2: Wt (syn), 3; Q291, 4; Q314, 5: Q351,
6: Double mutant Q314+Q351, 7; Triple Mutant Q291+Q314+Q351
In the cell extracts (B) a similar picture can be seen as far as the single mutation products 
are concerned, although there is also evidence of a product in the case of the double mutant
119
Q314 + Q351. Some partial products of possibly degradation (lower bands) or the presence 
of attached accessory proteins encountered during the secretion process could also be 
contributing to the higher bands seen in this gel.
Figure A.7: Colony growth on a tributyrin plate of P. pastoris,
A colony of each of the transformed cultures of P. pastoris containing 
the wild type and mutant lipase was plated out onto a fresh tributyrin plate 
and the extent of the opaque area around each colony growth was related to 
the activity of the lipase secreted.
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The activity of the various lipase enzyme is shown on the above tributyrin plate (Fig. 7.7). 
Colonies of similar size were giown from the original transformed Pichia and allowed to 
grow for 48 hours. The activity shown above indicates the following hierarchy of 
expression as noted by the size of halo around each colony: wild"type>Q291>Q314>Q351. 
Such differences in the size of the halo generated around each colony could be related 
primarily to the extent of expression as these have been noted to be different (FigA.6 a,b) 
or it might be that the actual activity of the enzymes are different.
Concluding remarks
These initial results are encouraging and have given some idea as to the effect of the 
mutations on protein size (Fig A.6 a,b) and possible expression and activity levels (Fig. 
A.7). It is anticipated that future work will look in gieater detail at the size of the secreted 
product, the secretion mechanism, and ultimately the investigation of the activity and 
kinetics of the purified protein.
1 2 1
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